MIRA INFORM REPORT

 

 

Report Date :

16.01.2014

 

IDENTIFICATION DETAILS

 

Name :

SK CHEMICALS CO LTD

 

 

Registered Office :

686, Sampyeong-Dong, Bundang-Gu  Seongnam, 463400

 

 

Country :

South Korea

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

01.07.1969

 

 

Legal Form :

Public Parent

 

 

Line of Business :

Manufacture and distribution of chemicals.

 

 

No. of Employees :

1,767

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but Correct

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

South Korea

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

SOUTH KOREA - ECONOMIC OVERVIEW

 

South Korea over the past four decades has demonstrated incredible growth and global integration to become a high-tech industrialized economy. In the 1960s, GDP per capita was comparable with levels in the poorer countries of Africa and Asia. In 2004, South Korea joined the trillion dollar club of world economies, and is currently the world's 12th largest economy. Initially, a system of close government and business ties, including directed credit and import restrictions, made this success possible. The government promoted the import of raw materials and technology at the expense of consumer goods, and encouraged savings and investment over consumption. The Asian financial crisis of 1997-98 exposed longstanding weaknesses in South Korea's development model including high debt/equity ratios and massive short-term foreign borrowing. GDP plunged by 6.9% in 1998, and then recovered by 9% in 1999-2000. Korea adopted numerous economic reforms following the crisis, including greater openness to foreign investment and imports. Growth moderated to about 4% annually between 2003 and 2007. Korea''s export focused economy was hit hard by the 2008 global economic downturn, but quickly rebounded in subsequent years, reaching 6.3% growth in 2010. The US-South Korea Free Trade Agreement was ratified by both governments in 2011 and went into effect in March 2012. Throughout 2012 the economy experienced sluggish growth because of market slowdowns in the United States, China, and the Eurozone. The incoming administration in 2013, following the December 2012 presidential election, is likely to face the challenges of balancing heavy reliance on exports with developing domestic-oriented sectors, such as services. The South Korean economy''s long term challenges include a rapidly aging population, inflexible labor market, and heavy reliance on exports - which comprise half of GDP.

Source : CIA

 

 

Company name and address

 

SK CHEMICALS CO LTD                      

 

686, Sampyeong-Dong, Bundang-Gu

Seongnam, 463400

Korea, Republic of

 

 

Tel:

82-2-20082008

Fax:

82-2-20082009

 

www.skchemicals.com

 

Employees:

1,767

Company Type:

Public Parent

Corporate Family:

4 Companies

Traded:

Korea Stock Exchange:

006120

Incorporation Date:

01-Jul-1969

Auditor:

KPMG LLP

Financials in:

USD (In Millions)

Fiscal Year End:

31-Dec-2012

Reporting Currency:

South Korean Won

Annual Sales:

8,128.9  1

Net Income:

70.8

Total Assets:

4,683.0  2

Market Value:

842.3

 

(23-Aug-2013)

 

    

Company other address

 

600, Jeongia 1-Dong Jangan-Gu, Suwaon-Si Gyeonggi-Do Korea 440745

Tel No.:- 82-31-245-3131

Fax No.:- 81-31-247-2004

 

 

Business Description        

 

 

SK Chemicals Co., Ltd. is a Korea-based manufacture and distribution of chemicals. The Company operates in four business divisions: green chemicals, life science, gas and other business divisions. Its green chemicals business division provides polyethylene terephthalate glycol (PETG) resins, carbon fibers, polyester binders, water treatment chemicals, biodiesels, polyethylene terephthalate (PET) resins and others. Its life science business division provides products for improving the blood circulation, remedies for arthritis, vaccines and blood preparations, as well as distributes medical equipment. Its gas business division imports, stores and distributes liquefied petroleum gas (LPG). Its other business division provides electronic medical record (EMR) and other information technology (IT) solutions for hospitals, pharmacies and others. For the three months ended 31 March 2013, SK Chemicals Co Ltd revenues decreased 19% to W1.886T. Net loss applicable to common stockholders totaled W27.97B vs. income of W59.74B. Revenues reflect Gas segment decrease of 24% to W1.513T, Other segment decrease of 34% to W25.43B, South Korea segment decrease of 18% to W1.1T, Japan segment decrease of 39% to W312.92B, China segment decrease of 38% to W26.96B.

 

 

Industry            

 

 

Industry

Synthetic Chemical Manufacturing

ANZSIC 2006:

1821 - Synthetic Resin and Synthetic Rubber Manufacturing

ISIC Rev 4:

2013 - Manufacture of plastics and synthetic rubber in primary forms

NACE Rev 2:

2016 - Manufacture of plastics in primary forms

NAICS 2012:

325211 - Plastics Material and Resin Manufacturing

UK SIC 2007:

2016 - Manufacture of plastics in primary forms

US SIC 1987:

2821 - Plastics Materials, Synthetic Resins, and Nonvulcanizable Elastomers

 

 

 

Key Executives

 

Name

Title

Chang Won Choi

Vice Chairman of the Board, Co-Chief Executive Officer

Mun Seok Lee

President, Co-Chief Executive Officer, Director

Dong Hyeon Ahn

Assistant Managing Director

Deok Geun Ahn

Non-Executive Independent Director

Tae Shin Gwon

Non-Executive Independent Director

 

 

Significant Developments

 

Topic

#*

Most Recent Headline

Date

Officer Changes

2

SK Chemicals Co., Ltd. Appoints New Co-CEO

22-Mar-2013

Strategic Combinations

1

SK Chemicals Co., Ltd. to Jointly Establish New Company

31-Jan-2013

General Products

1

SK Chemicals Co., Ltd. to Invest in Production Facilities

20-Dec-2012

Equity Investments

2

SK Chemicals Co., Ltd. Announces Changes in Shareholding Structure

2-May-2013

Dividends

1

SK Chemicals Co., Ltd. Declares Annual Cash Dividend for FY 2012

31-Jan-2013

* number of significant developments within the last 12 months

 

 

News

 

Title

Date

FUSION PROTEIN HAVING FACTOR IX ACTIVITY
European Patents (92 Words)

5-Sep-2013

WIPO PUBLISHES PATENT OF SK CHEMICALS FOR "NOVEL FUNGAL STRAIN FOR PRODUCING CELLULASE AND SACCHARIFICATION METHOD USING SAME" (SOUTH KOREAN...
U.S. Fed News (227 Words)

31-Aug-2013

WIPO PUBLISHES PATENT OF SK CHEMICALS FOR "MICROORGANISM CULTIVATOR FOR INDUCING ACTIVATION OF ANAEROBIC DIGESTION OF ORGANIC WASTE" (SOUTH KOREAN...
U.S. Fed News (348 Words)

16-Aug-2013

S.Korea shares set to fall as US data heighten Fed tapering speculation
Reuters (393 Words)

15-Aug-2013

Agency Reviews Patent Application Approval Request for "Mdck-Derived Cell Lines Adapted to Serum-Free Culture and Suspension Culture and Method for...
Life Science Weekly (1911 Words)

31-Jul-2013

MDCK-DERIVED CELL LINES ADAPTED TO SERUM-FREE CULTURE AND SUSPENSION CULTURE AND METHOD FOR PREPARING VACCINE VIRUS USING THE CELLS
European Patents (159 Words)

29-Jul-2013

 

 

Financial Summary

 

As of 31-Mar-2013

Key Ratios

Company

Industry

Current Ratio (MRQ)

1.37

2.18

Quick Ratio (MRQ)

1.06

1.35

Debt to Equity (MRQ)

1.65

0.82

Sales 5 Year Growth

10.04

6.26

Net Profit Margin (TTM) %

0.74

10.56

Return on Assets (TTM) %

1.42

8.26

Return on Equity (TTM) %

-0.73

22.07

 

 

Stock Snapshot

 

Traded: Korea Stock Exchange: 006120

 

As of 23-Aug-2013

   Financials in: KRW

Recent Price

43,300.00

 

EPS

4,836.78

52 Week High

71,300.00

 

Price/Sales

0.10

52 Week Low

37,650.00

 

Dividend Rate

400.00

Avg. Volume (mil)

0.11

 

Price/Book

0.60

Market Value (mil)

943,633.90

 

Beta

1.18

 

Price % Change

Rel S&P 500%

4 Week

2.36%

4.59%

13 Week

0.58%

6.13%

52 Week

-30.16%

-27.45%

Year to Date

-27.47%

-22.55%

 

 

1 - Profit & Loss Item Exchange Rate: USD 1 = KRW 1126.849
2 - Balance Sheet Item Exchange Rate: USD 1 = KRW 1066.4

 

 

 

Corporate Overview

 

 

Location
686, Sampyeong-Dong, Bundang-Gu
Seongnam, 463400
Korea, Republic of

 

Tel:

82-2-20082008

Fax:

82-2-20082009

 

www.skchemicals.com

Quote Symbol - Exchange

006120 - Korea Stock Exchange

Sales KRW(mil):

9,160,085.0

Assets KRW(mil):

4,993,945.0

Employees:

1,767

Fiscal Year End:

31-Dec-2012

 

Industry:

Chemicals - Plastics and Rubber

Incorporation Date:

01-Jul-1969

Company Type:

Public Parent

Quoted Status:

Quoted

 

Vice Chairman of the Board, Co-Chief Executive Officer:

Chang Won Choi

 

Industry Codes

 

ANZSIC 2006 Codes:

1821

-

Synthetic Resin and Synthetic Rubber Manufacturing

1915

-

Adhesive Manufacturing

1701

-

Petroleum Refining and Petroleum Fuel Manufacturing

5420

-

Software Publishing

3491

-

Professional and Scientific Goods Wholesaling

2700

-

Gas Supply

1841

-

Human Pharmaceutical and Medicinal Product Manufacturing

1829

-

Other Basic Polymer Manufacturing

 

ISIC Rev 4 Codes:

2013

-

Manufacture of plastics and synthetic rubber in primary forms

2029

-

Manufacture of other chemical products n.e.c.

3520

-

Manufacture of gas; distribution of gaseous fuels through mains

4649

-

Wholesale of other household goods

2100

-

Manufacture of pharmaceuticals, medicinal chemical and botanical products

1920

-

Manufacture of refined petroleum products

5820

-

Software publishing

2030

-

Manufacture of man-made fibres

 

NACE Rev 2 Codes:

2016

-

Manufacture of plastics in primary forms

3522

-

Distribution of gaseous fuels through mains

2052

-

Manufacture of glues

2060

-

Manufacture of man-made fibres

2120

-

Manufacture of pharmaceutical preparations

4646

-

Wholesale of pharmaceutical goods

1920

-

Manufacture of refined petroleum products

5829

-

Other software publishing

 

NAICS 2012 Codes:

325211

-

Plastics Material and Resin Manufacturing

324110

-

Petroleum Refineries

325414

-

Biological Product (except Diagnostic) Manufacturing

325520

-

Adhesive Manufacturing

423450

-

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

325412

-

Pharmaceutical Preparation Manufacturing

325220

-

Artificial and Synthetic Fibers and Filaments Manufacturing

221210

-

Natural Gas Distribution

511210

-

Software Publishers

 

US SIC 1987:

2821

-

Plastics Materials, Synthetic Resins, and Nonvulcanizable Elastomers

7372

-

Prepackaged Software

2911

-

Petroleum Refining

2824

-

Manmade Organic Fibers, Except Cellulosic

2891

-

Adhesives and Sealants

5047

-

Medical, Dental, and Hospital Equipment and Supplies

4923

-

Natural Gas Transmission and Distribution

2836

-

Biological Products, Except Diagnostic Substances

2834

-

Pharmaceutical Preparations

 

UK SIC 2007:

2016

-

Manufacture of plastics in primary forms

3522

-

Distribution of gaseous fuels through mains

2052

-

Manufacture of glues

2060

-

Manufacture of man-made fibres

2120

-

Manufacture of pharmaceutical preparations

4646

-

Wholesale of pharmaceutical goods

1920

-

Manufacture of refined petroleum products

5829

-

Other software publishing

 

 

Business Description

 

SK Chemicals Co., Ltd. is a Korea-based manufacture and distribution of chemicals. The Company operates in four business divisions: green chemicals, life science, gas and other business divisions. Its green chemicals business division provides polyethylene terephthalate glycol (PETG) resins, carbon fibers, polyester binders, water treatment chemicals, biodiesels, polyethylene terephthalate (PET) resins and others. Its life science business division provides products for improving the blood circulation, remedies for arthritis, vaccines and blood preparations, as well as distributes medical equipment. Its gas business division imports, stores and distributes liquefied petroleum gas (LPG). Its other business division provides electronic medical record (EMR) and other information technology (IT) solutions for hospitals, pharmacies and others. For the three months ended 31 March 2013, SK Chemicals Co Ltd revenues decreased 19% to W1.886T. Net loss applicable to common stockholders totaled W27.97B vs. income of W59.74B. Revenues reflect Gas segment decrease of 24% to W1.513T, Other segment decrease of 34% to W25.43B, South Korea segment decrease of 18% to W1.1T, Japan segment decrease of 39% to W312.92B, China segment decrease of 38% to W26.96B.

 

More Business Descriptions

Production of advanced fibres including polyester filament yarn, staple fibre, acetate and flexible fabrics for outdoor use; specialty chemicals for adhesives, automotive chemicals, water treatment chemicals, coatings and pet resins for bottles; DMT/TPA production

SK Chemicals Co., Ltd. (SK Chemicals) is a chemical product manufacturer. The company along with its subsidiaries manufactures coatings, adhesive resins, resins, biocides, water treatment chemicals and electro chemicals. It also manufactures polyester and acetate yarns for textile, garment and industrial uses. SK Chemicals provides herbal medicines, vaccines, pet resins, carbon fiber composite material, bio- diesel and acetate fiber. It was formerly known as SK Sunkyong Industries Ltd.The company operates through two segments, namely, Green Chemicals and Life Science.Its Green Chemicals segment is comprised of division such as PET Resins, PETG Resins, Polyester Binders, Carbon Fiber Composite and ECOZEN. SK Chemicals’ PETG Resins division offers SKYGREEN, which is used in various applications such as end cosmetic containers, building materials, advertising materials and parts for household appliances. It includes SKYGREEN PETG S2008 and SKYGREEN PETG K2012. The company, through its PET Resins division provides PET resins through its SKYPET brand. It has the capacity to produce 80,000 MT of PET resins annually. Its Polyester Binders division offers SKYBON, which is a molecular and saturated co-polyester resin, is widely used in coil coating and can coating. SK Chemicals provides three types of products, which include solvent-borne type, water-borne type and hotmelt type. The company’s Carbon Fiber Composite division offers composite materials that are used in sports/leisure fields, which consist of fishing rods and arrows, gold shaft, boat, yacht, tennis and badminton racker, and for parts for materials in airplanes, cars and industrial robots and also used to reinforce buildings and civil structures against natural disasters. It has commercialized ECOZEN, which is a plastic resin which incorporates the Bio Monomer solution.The company’s Life Science segment consists of divisions such as synthetic drugs, natural products, biological pharmaceuticals and drug delivery system.Its Synthetic Drug division provides SUNPLA, which is a patent registered in more than 20 countries; and Mvix drug for erectile dysfunction treatment. Through its Natural Products division, SK Chemicals manufactures ‘JOINS’, which is extracted from herbs such as Clematidis Radix, Prunellae Spica, Trichosanthis Radix for arthritis treatment; and Ginexin, which is used for improvement of blood circulation. The Biological Pharmaceuticals division manufactures and markets vaccine, blood preparation, insulin, interferon, antitoxin, parenteral nutrition, antibiotics and diagnostic agents. The Drug Delivery System division of the company offers TRAST, the antiarthritis patch; and OMED an oral antiulcer agent. SK Chemicals is working for the development of IMD (Incrementally Modified Drug) for the treatment of obesity, hypertension and asthma. Through its Biotech division, it operates through In2Gen, which is a joint venture with the Seoul National University Cancer Center for the development of new drugs. The company operates through its subsidiaries such as SK CYTEC, SK Chemicals QingdaoH, SK E&C, SK Pharma Beijing and SK Chemicals Suzhou. It also carries out R&D activities for its product development. Geographically, the company operates through its offices located in South Korea, the US, China, Japan, Germany and Singapore.In April 2013, SK Biopharmaceuticals has announced that it has entered into a co-development agreement with SK Chemicals for its novel new small molecule YKP10811, which is being developed for the treatment of irritable bowel syndrome with constipation (IBS-C).

SK Chemicals Co., Ltd. (SK Chemicals) is a chemical products manufacturing company. The company operates through segments such as Green Chemicals and Life Science. It through its subsidiaries manufactures coatings, adhesive resins, resins, biocides, water treatment chemicals and electro chemicals. SK Chemicals also manufactures polyester and acetate yarns for textile, garment, and industrial uses. The company provides herbal medicines, vaccines, pet resins, carbon fiber composite material, bio- diesel and acetate fiber. Its products consist of PET Resins, PETG Resins, Biodiesel, Polyester Binders, Industrial Biocides/Water Treatment Chemicals, and Solvent/Imaging Chemicals. The company operates in worldwide countries, which include the US, China, Japan, Germany and Singapore. SK Chemicals is headquartered in Seoul, Korea.The company reported revenues of (Won) KRW 9,160,084.62 million during the fiscal year ended December 2012, an increase of 3.33% over 2011. The operating profit of the company was KRW 190,624.14 million during the fiscal year 2012, a decrease of 17.43% from 2011. The net profit of the company was KRW 79,783.33 million during the fiscal year 2012, a decrease of 48.10% from 2011.

All Other Chemical Product and Preparation Manufacturing

 

 

Financial Data

 

Financials in:

KRW(mil)

 

Revenue:

9,160,085.0

Net Income:

79,783.3

Assets:

4,993,945.0

Long Term Debt:

1,192,261.1

 

Total Liabilities:

3,703,643.8

 

Working Capital:

-165.8

 

 

 

Date of Financial Data:

31-Dec-2012

 

1 Year Growth

3.3%

-58.4%

23.8%

 

 

Market Data

 

Quote Symbol:

006120

Exchange:

Korea Stock Exchange

Currency:

KRW

Stock Price:

43,300.0

Stock Price Date:

08-23-2013

52 Week Price Change %:

-30.2

Market Value (mil):

943,633,920.0

 

SEDOL:

6859916

ISIN:

KR7006120000

 

Equity and Dept Distribution:

All financials reflects consolidated numbers. '08 is restated.

 

 

Subsidiaries

 

Company

Percentage Owned

Country

SK Chemicals Suzhou Co Ltd

100%

PEOPLE'S REPUBLIC OF CHINA

SK Pharma Beijing Co Ltd

100%

PEOPLE'S REPUBLIC OF CHINA

 

 

 

Shareholders

 

 

 

Major Shareholders

SK Holding

 

 

Key Corporate Relationships

 

Auditor:

KPMG LLP

 

Auditor:

KPMG LLP

 

 

 

 

Corporate Family      

 

Corporate Structure News:

 

Total Corporate Family Members: 4

 

Company Name

Company Type

Location

Country

Industry

Sales
(USD mil)

Employees

SK Chemicals Co Ltd

Parent

Seongnam

Korea, Republic of

Synthetic Chemical Manufacturing

8,128.9

1,767

Sk Chemicals (Qingdao) Co., Ltd.

Subsidiary

Qingdao, Shandong

China

Synthetic Chemical Manufacturing

 

40

SK Chemicals Suzhou Co Ltd

Subsidiary

Wujing, Jiangsu Province

China

Basic Chemical Manufacturing

 

 

SK Pharma Beijing Co Ltd

Subsidiary

Beijing

China

Health and Personal Care Wholesale

 

 

 

 

 

Competitors Report

 

CompanyName

Location

Employees

Ownership

Dongbu HiTeck Co., LTD.

Seoul, Korea, Republic of

2,326

Public

Oci Co Ltd

Seoul, Korea, Republic of

2,761

Public

Samsung Fine Chemicals Co Ltd

Ulsan, Korea, Republic of

1,110

Public

Taekwang Industrial Co., Ltd.

Seoul, Korea, Republic of

1,674

Public

 

 

 

Executives Report

 

Board of Directors

Name

Title

Function

Chang Won Choi

 

Vice Chairman of the Board, Co-Chief Executive Officer

Vice-Chairman

Biography:

Choi Chang Won has been Vice Chairman of the Board and Co-Chief Executive Officer of SK Chemicals Co., Ltd. since December 28, 2006. Choi also serves as Vice Chairman and Chief Executive Officer of SK Engineering & Construction co., ltd and SK GAS LTD. Previously Choi served the Company as Vice President, Head of Management Support Division and Head of Planning Division. Choi received a Bachelor's degree in Psychology from Seoul National University, Korea and a Master of Business Administration from University of Michigan, the United States.

Age: 48

Education:

University of Michigan, MBA
Seoul National University, B (Psychology)

Deok Geun Ahn

 

Non-Executive Independent Director

Director/Board Member

 

Age: 45

Education:

University of Michigan, PHD (Economics)
University of Michigan, PHD (Law)
Seoul National University, B (Economics)

Tae Shin Gwon

 

Non-Executive Independent Director

Director/Board Member

 

Biography:

Gwon Tae Shin has been Non-Executive Independent Director in SK Chemicals Co., Ltd. since March 21, 2011. Gwon is also Independent Director in another Korea-based company. Gwon holds a Bachelor's degree in Economics from Seoul National University, Korea and a Master of Business Administration from London Metropolitan University, the United Kingdom.

Age: 63

Education:

London Metropolitan University, MBA
Seoul National University, B (Economics)

Gi Ho Huh

 

Non-Executive Independent Director

Director/Board Member

 

Biography:

Huh Gi Ho has been Non-Executive Independent Director of SK Chemicals Co., Ltd. since March 14, 2008. Huh also serves as Vice Chairman and Chief Executive Officer of HANILCEMENTCO.,LTD. Huh holds a Bachelor's degree in Economics from Sungkyunkwan University, Korea and a Master of Business Administration from Thunderbird University, the United States.

Age: 46

Education:

Thunderbird University, MBA
Sungkyunkwan University, B (Economics)

Bo Hyeon Kang

 

Non-Executive Independent Director

Director/Board Member

 

Biography:

Kang Bo Hyeon has been Non-Executive Independent Director of SK Chemical Co., Ltd. since March 11, 2005. Currently, Kang is also a lawyer of a Korea-based law firm. Kang was a judge of Seoul High Court and a Professor. Kang holds a Bachelor's degree in Law from Seoul National University, Korea.

Age: 64

Education:

Seoul National University, B (Law)

Mun Seok Lee

 

President, Co-Chief Executive Officer, Director

Director/Board Member

 

Biography:

Lee Mun Seok has been President, Co-Chief Executive Officer and Director of SK Chemicals Co., Ltd. since March 22, 2013. Previously, Lee served the Company as Vice President, Managing Director and Assistant Managing Director. Lee currently also serves as President of Green Chemicals Biz., Director of HUVIS CORPORATION, as well as Chief Executive Officer in another company. Lee holds a Bachelor's degree in Textile Engineering from Kyung Hee University, Korea.

Age: 59

Education:

Kyung Hee University, B (Textile Engineering)

Yin Seok Lee

 

Co-Chief Executive Officer, Vice President, Director

Director/Board Member

 

Biography:

Lee Yin Seok has been serving as Co-Chief Executive Officer, Vice President and Director of SK Chemical Co., Ltd. since March 27, 2012. Currently, Lee also serves as President at Life Science Biz. Previously, Lee served the Company as Managing Director, Assistant Managing Director and Head of Marketing Division. Lee holds a Bachelor's degree in Chemical Engineering from Dankook University, Korea.

Age: 58

Education:

Dankook University, B (Chemical Engineering)

 

Executives

 

Name

Title

Function

Chang Won Choi

 

Vice Chairman of the Board, Co-Chief Executive Officer

Chief Executive Officer

Biography:

Choi Chang Won has been Vice Chairman of the Board and Co-Chief Executive Officer of SK Chemicals Co., Ltd. since December 28, 2006. Choi also serves as Vice Chairman and Chief Executive Officer of SK Engineering & Construction co., ltd and SK GAS LTD. Previously Choi served the Company as Vice President, Head of Management Support Division and Head of Planning Division. Choi received a Bachelor's degree in Psychology from Seoul National University, Korea and a Master of Business Administration from University of Michigan, the United States.

Age: 48

Education:

University of Michigan, MBA
Seoul National University, B (Psychology)

Mun Seok Lee

 

President, Co-Chief Executive Officer, Director

Chief Executive Officer

 

Biography:

Lee Mun Seok has been President, Co-Chief Executive Officer and Director of SK Chemicals Co., Ltd. since March 22, 2013. Previously, Lee served the Company as Vice President, Managing Director and Assistant Managing Director. Lee currently also serves as President of Green Chemicals Biz., Director of HUVIS CORPORATION, as well as Chief Executive Officer in another company. Lee holds a Bachelor's degree in Textile Engineering from Kyung Hee University, Korea.

Age: 59

Education:

Kyung Hee University, B (Textile Engineering)

Yin Seok Lee

 

Co-Chief Executive Officer, Vice President, Director

Chief Executive Officer

 

Biography:

Lee Yin Seok has been serving as Co-Chief Executive Officer, Vice President and Director of SK Chemical Co., Ltd. since March 27, 2012. Currently, Lee also serves as President at Life Science Biz. Previously, Lee served the Company as Managing Director, Assistant Managing Director and Head of Marketing Division. Lee holds a Bachelor's degree in Chemical Engineering from Dankook University, Korea.

Age: 58

Education:

Dankook University, B (Chemical Engineering)

Dong Hyeon Ahn

 

Assistant Managing Director

Managing Director

 

Age: 50

Education:

Sogang University, B (Business Administration)

Jae Ho Bae

 

Assistant Managing Director

Managing Director

 

Age: 49

Education:

ChungNam National University, B (Accounting)

Nak Jong Choi

 

Assistant Managing Director

Managing Director

 

Age: 50

Education:

Hankuk University of Foreign Studies, M (Business Administration)

Byeong Ro Han

 

Managing Director

Managing Director

 

Age: 53

Education:

Korea University, BBA

Yin Seok Hwang

 

Assistant Managing Director

Managing Director

 

Age: 53

Education:

Yeungnam University, B

Gwang Hyeon Jeon

 

Assistant Managing Director

Managing Director

 

Age: 48

Education:

Korea University, B (Business Administration)

Yeong Hwi Jin

 

Assistant Managing Director

Managing Director

 

Age: 51

Education:

Rutgers University, M (Business Administration)

Cheol Jin Kim

 

Assistant Managing Director

Managing Director

 

Age: 57

Education:

Yonsei University, B (Mechanical Engineering)

Gyeong Ho Kim

 

Assistant Managing Director

Managing Director

 

Age: 54

Education:

Seoul National University, B

Jung Beom Kim

 

Assistant Managing Director

Managing Director

 

Age: 56

Education:

Kyung Hee University, B (Business Administration)

Jong Ryang Kim

 

Assistant Managing Director

Managing Director

 

Age: 49

Education:

Case Western Reserve University, PHD
Seoul National University, M

Jeong Tae Kim

 

Assistant Managing Director

Managing Director

 

Age: 45

Education:

University of Michigan, MBA
Yonsei University, B (Business Administration)

Hyeon Seok Kim

 

Assistant Managing Director

Managing Director

 

Age: 46

Education:

University of North Carolina, MBA
Yonsei University, B (Biochemistry)

Hun Taek Kim

 

Assistant Managing Director

Managing Director

 

Age: 46

Education:

Texas A&M University, PHD
Seoul National University, M (Pathology)
Seoul National University, B (Veterinary Science)

Eung Yun Lee

 

Assistant Managing Director

Managing Director

 

Age: 50

Education:

Sungkyunkwan University, B (Chemical Engineering)

Gwang Seok Lee

 

Assistant Managing Director

Managing Director

 

Age: 50

Education:

Pusan National University, B (Business Administration)

Seung Jin Lee

 

Assistant Managing Director

Managing Director

 

Age: 43

Education:

Yonsei University, B (Chemical Engineering)
Korea Advanced Institute of Science and Technology, B (Chemical Engineering)
Purdue University, B (Chemical Engineering)

Tae Wung Lee

 

Assistant Managing Director

Managing Director

 

Age: 52

Education:

Korea Advanced Institute of Science and Technology, DS (Chemical Engineering)
Korea Advanced Institute of Science and Technology, M (Chemical Engineering)
Seoul National University, B (Chemical Engineering)

Jong Hyeon Park

 

Assistant Managing Director

Managing Director

 

Age: 42

Education:

Stanford University, B (Aeronautics and Astronautics)

Chan Jung Park

 

Managing Director

Managing Director

 

Biography:

Park Chan Jung is Managing Director of SK Chemicals Co., Ltd. Park was Assistant Managing Director of the Company and Chief Executive Officer of n2gen. Park holds a Bachelor and a Master's degrees in Business Administration from Seoul National University, Korea and a Master of Business Administration from University of Michigan, the United States.

Age: 48

Education:

Michigan University, MBA
Seoul National University, M (Business Administration)
Seoul National University, B (Business Administration)

Man Hun Park

 

Managing Director

Managing Director

 

Age: 56

Education:

Ottawa University, MD (Virology)

Jong Hyeon Park

 

Assistant Managing Director

Managing Director

 

Age: 42

Seop Park

 

Assistant Managing Director

Managing Director

 

Age: 57

Education:

Inha University, M (Chemistry)
Inha University, B (Chemistry)

Cheol Park

 

Managing Director

Managing Director

 

Age: 46

Education:

Seoul National University, B

Su Jin Song

 

Assistant Managing Director

Managing Director

 

Age: 42

Education:

Pohang University of Science and Technology, B
Northwestern University, B (Materials Science and Engineering)

Jeong Yil Yang

 

Assistant Managing Director

Managing Director

 

Age: 44

Education:

Seoul National University, PHD (Law)

Seung Gyu Yim

 

Assistant Managing Director

Managing Director

 

Age: 54

Education:

Korea Advanced Institute of Science and Technology, PHD (Chemical Engineering)

Jae Bong Yim

 

Assistant Managing Director

Managing Director

 

Age: 53

Education:

Seoul National University, B (Chemical Engineering)

 

 Significant Developments

 

 

 

SK Chemicals Co., Ltd. Announces Changes in Shareholding Structure

May 02, 2013


SK Chemicals Co., Ltd. announced that Mirae Asset Global Investments Co.,Ltd. and seven related parties have sold 688,126 shares of the Company, equivalent to a 3.30% stake. After the transaction, Mirae Asset Global Investments Co.,Ltd. and five related parties' stake in the Company has decreased to 5.39% from 8.69%.

SK Chemicals Co., Ltd. Appoints New Co-CEO

Mar 22, 2013


SK Chemicals Co., Ltd. announced that it has appointed Lee Mun Seok as its new Co-Chief Executive Officer (Co-CEO), effective March 22, 2013. The current Co-CEOs, Choi Chang Won and Lee Yin Seok, continue their duties as Co-CEOs at the Company.

SK Chemicals Co., Ltd. Announces Resignation of Co-CEO

Feb 28, 2013


SK Chemicals Co., Ltd. announced that its Co-Chief Executive Officer (Co-CEO) Kim Chang Geun has resigned from the Company, effective February 28, 2013. The current Co-CEO Choi Chang Won and Lee Yin Seok, will continue the duties as Co-Chief Executive Officers at the Company.

SK Chemicals Co., Ltd. to Jointly Establish New Company

Jan 31, 2013


SK Chemicals Co., Ltd. announced that it will jointly establish a new company on July 31, 2013, to foray into poly phenylene sulfine (PPS) business. The new entity, to be capitalized at KRW 5 billion, will be mainly engaged in the manufacturing and sales of poly phenylene sulfine. The Company will invest KRW 60,999 million, holding a 66% stake in it.

SK Chemicals Co., Ltd. Declares Annual Cash Dividend for FY 2012

Jan 31, 2013


SK Chemicals Co., Ltd. announced that its Board of Directors has declared an annual cash dividend of KRW 400 per share of common stock and KRW 450 per share of preferred stock for the fiscal year 2012 to shareholders of record on December 31, 2012. The dividend rates of market prices are 0.7% (common shares) and 3.2% (preferred shares), respectively. The total cash dividend amount is KRW 8,310,283,850.

SK Chemicals Co., Ltd. to Invest in Production Facilities

Dec 20, 2012


SK Chemicals Co., Ltd. announced that it will invest KRW 178 billion in production facilities to increase the production during the period from January 1, 2013 to December 31, 2015.

SK Chemicals Co., Ltd. to Acquire Stake in Kopla Co Ltd

Oct 15, 2012


Kopla Co Ltd announced that SK Chemicals Co., Ltd. and another investor have acquired 898,429 shares of Kopla Co Ltd, representing a 10.33% stake.

 

 

News

 

FUSION PROTEIN HAVING FACTOR IX ACTIVITY
European Patents (92 Words)

05-Sep-2013

WIPO PUBLISHES PATENT OF SK CHEMICALS FOR "NOVEL FUNGAL STRAIN FOR PRODUCING CELLULASE AND SACCHARIFICATION METHOD USING SAME" (SOUTH KOREAN...
U.S. Fed News (227 Words)

31-Aug-2013

WIPO PUBLISHES PATENT OF SK CHEMICALS FOR "MICROORGANISM CULTIVATOR FOR INDUCING ACTIVATION OF ANAEROBIC DIGESTION OF ORGANIC WASTE" (SOUTH KOREAN...
U.S. Fed News (348 Words)

16-Aug-2013

S.Korea shares set to fall as US data heighten Fed tapering speculation
Reuters (393 Words)

15-Aug-2013

Agency Reviews Patent Application Approval Request for "Mdck-Derived Cell Lines Adapted to Serum-Free Culture and Suspension Culture and Method for...
Life Science Weekly (1911 Words)

31-Jul-2013

MDCK-DERIVED CELL LINES ADAPTED TO SERUM-FREE CULTURE AND SUSPENSION CULTURE AND METHOD FOR PREPARING VACCINE VIRUS USING THE CELLS
European Patents (159 Words)

29-Jul-2013

COMPOSITION FOR PERCUTANEOUS ADMINISTRATION OF TOLTERODINE WITH REDUCED SKIN IRRITATION
European Patents (66 Words)

29-Jul-2013

COMPOSITION FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME
European Patents (89 Words)

29-Jul-2013

Method for production of polyarylene sulfide resin with excellent luminosity and the polyarylene sulfide resin
U.S. Patents (260 Words)

29-Jul-2013

MDCK-DERIVED CELL LINES ADAPTED TO SERUM-FREE CULTURE AND SUSPENSION CULTURE AND METHOD FOR PREPARING VACCINE VIRUS USING THE CELLS
European Patents (159 Words)

23-Jul-2013

COMPOSITION FOR PERCUTANEOUS ADMINISTRATION OF TOLTERODINE WITH REDUCED SKIN IRRITATION
European Patents (66 Words)

23-Jul-2013


Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Reclassified Normal
31-Dec-2012

Restated Normal
31-Dec-2011

Restated Normal
31-Dec-2010

Restated Normal
31-Dec-2009

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate (Period Average)

1126.848795

1107.891393

1156.281981

1276.385219

1100.562842

Auditor

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified with Explanation

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

    Net Sales

8,063.3

7,973.5

1,247.8

1,090.6

1,516.3

Revenue

8,063.3

7,973.5

1,247.8

1,090.6

1,516.3

    Other Revenue

65.6

28.2

14.1

-

-

Other Revenue, Total

65.6

28.2

14.1

-

-

Total Revenue

8,128.9

8,001.7

1,261.9

1,090.6

1,516.3

 

 

 

 

 

 

    Cost of Revenue

7,520.2

7,353.6

979.5

836.2

1,231.7

Cost of Revenue, Total

7,520.2

7,353.6

979.5

836.2

1,231.7

Gross Profit

543.2

619.8

268.3

254.4

284.6

 

 

 

 

 

 

    Selling/General/Administrative Expense

222.5

222.1

97.1

69.9

87.4

    Labor & Related Expense

108.8

103.9

55.7

48.2

51.0

    Advertising Expense

23.2

21.2

21.1

18.9

21.8

Total Selling/General/Administrative Expenses

354.5

347.2

173.9

137.0

160.2

Research & Development

58.3

62.3

46.1

34.3

32.2

    Depreciation

21.2

23.3

1.5

1.3

1.6

    Amortization of Intangibles

4.5

4.4

4.6

10.4

13.2

Depreciation/Amortization

25.7

27.6

6.1

11.7

14.8

    Other Unusual Expense (Income)

-

-

-

-

0.0

Unusual Expense (Income)

-

-

-

-

0.0

    Other Operating Expense

1.1

2.5

0.2

0.3

3.8

Other Operating Expenses, Total

1.1

2.5

0.2

0.3

3.8

Total Operating Expense

7,959.8

7,793.3

1,205.8

1,019.5

1,442.8

 

 

 

 

 

 

Operating Income

169.2

208.4

56.1

71.1

73.4

 

 

 

 

 

 

        Interest Expense - Non-Operating

-52.1

-38.5

-19.9

-37.7

-58.3

    Interest Expense, Net Non-Operating

-52.1

-38.5

-19.9

-37.7

-58.3

        Interest Income - Non-Operating

17.1

16.6

2.8

5.0

5.3

        Investment Income - Non-Operating

26.7

51.0

17.8

113.1

-51.4

    Interest/Investment Income - Non-Operating

43.8

67.6

20.6

118.1

-46.2

    Interest Income (Expense) - Net Non-Operating

0.0

-

0.0

-

-

Interest Income (Expense) - Net Non-Operating Total

-8.3

29.1

0.6

80.4

-104.5

Gain (Loss) on Sale of Assets

-7.2

-2.5

-13.3

-16.1

1.8

    Other Non-Operating Income (Expense)

15.7

15.0

154.1

-4.8

2.0

Other, Net

15.7

15.0

154.1

-4.8

2.0

Income Before Tax

169.4

250.0

197.6

130.6

-27.2

 

 

 

 

 

 

Total Income Tax

30.5

44.7

20.1

23.6

1.9

Income After Tax

139.0

205.3

177.5

107.0

-29.1

 

 

 

 

 

 

    Minority Interest

-68.2

-33.6

-1.5

-14.1

-49.3

    Equity In Affiliates

-

-

-

-

-0.7

Net Income Before Extraord Items

70.8

171.7

176.0

92.9

-79.2

    Discontinued Operations

0.0

-33.0

16.4

6.3

84.3

Total Extraord Items

0.0

-33.0

16.4

6.3

84.3

Net Income

70.8

138.7

192.3

99.2

5.1

 

 

 

 

 

 

    Preferred Dividends

-1.1

-1.1

-1.3

-1.2

-0.4

Total Adjustments to Net Income

-1.1

-1.1

-1.3

-1.2

-0.4

Income Available to Common Excl Extraord Items

69.7

170.6

174.6

91.7

-79.5

 

 

 

 

 

 

Income Available to Common Incl Extraord Items

69.7

137.6

191.0

98.0

4.8

 

 

 

 

 

 

Basic/Primary Weighted Average Shares

17.6

17.6

17.7

17.7

18.1

Basic EPS Excl Extraord Items

3.96

9.69

9.85

5.17

-4.40

Basic/Primary EPS Incl Extraord Items

3.96

7.82

10.77

5.53

0.26

Dilution Adjustment

0.0

0.0

0.0

-

-

Diluted Net Income

69.7

137.6

191.0

98.0

4.8

Diluted Weighted Average Shares

17.6

17.6

17.7

17.7

18.1

Diluted EPS Excl Extraord Items

3.96

9.69

9.85

5.17

-4.40

Diluted EPS Incl Extraord Items

3.96

7.82

10.77

5.53

0.26

Dividends per Share - Common Stock Primary Issue

0.35

0.36

0.43

0.39

0.09

Gross Dividends - Common Stock

-

-

7.6

7.0

1.6

Interest Expense, Supplemental

52.1

38.5

19.9

37.7

58.3

Interest Capitalized, Supplemental

-

-

-

-0.3

-0.6

Depreciation, Supplemental

59.2

51.2

27.0

39.3

63.2

Total Special Items

7.2

2.5

13.3

19.3

-0.8

Normalized Income Before Tax

176.6

252.5

210.8

149.8

-28.0

 

 

 

 

 

 

Effect of Special Items on Income Taxes

1.3

0.5

1.3

2.9

-0.6

Inc Tax Ex Impact of Sp Items

31.8

45.1

21.5

26.5

1.3

Normalized Income After Tax

144.9

207.4

189.4

123.4

-29.3

 

 

 

 

 

 

Normalized Inc. Avail to Com.

75.6

172.6

186.5

108.1

-79.7

 

 

 

 

 

 

Basic Normalized EPS

4.29

9.80

10.52

6.09

-4.41

Diluted Normalized EPS

4.29

9.80

10.52

6.09

-4.41

Amort of Acquisition Costs, Supplemental

-

-

-

3.2

1.0

Amort of Intangibles, Supplemental

5.2

4.8

4.7

10.2

12.9

Rental Expenses

9.9

9.7

0.7

0.6

0.7

Advertising Expense, Supplemental

23.2

21.2

21.1

18.9

21.8

Research & Development Exp, Supplemental

58.3

62.3

46.1

34.3

32.2

Normalized EBIT

169.2

208.4

56.1

71.1

73.5

Normalized EBITDA

233.5

264.3

87.8

123.9

150.6

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Restated Normal
31-Dec-2011

Updated Normal
31-Dec-2009

Updated Normal
31-Dec-2008

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate

1066.400024

1152

1134.9

1164.475

1259.55

Auditor

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified with Explanation

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

    Cash & Equivalents

716.0

161.9

277.9

56.7

90.3

    Short Term Investments

20.0

23.0

45.4

54.3

98.8

Cash and Short Term Investments

736.0

184.9

323.3

111.1

189.1

        Accounts Receivable - Trade, Gross

997.7

801.6

658.4

270.4

1,403.4

        Provision for Doubtful Accounts

-9.0

-8.0

-7.1

-6.7

-92.7

    Trade Accounts Receivable - Net

992.5

794.9

652.5

264.2

1,313.3

    Other Receivables

80.0

82.3

75.3

27.1

218.1

Total Receivables, Net

1,072.5

877.2

727.8

291.3

1,531.4

    Inventories - Finished Goods

233.8

167.6

163.5

104.3

208.6

    Inventories - Work In Progress

56.1

51.3

36.6

45.2

119.1

    Inventories - Raw Materials

56.4

59.3

33.6

45.4

186.4

    Inventories - Other

281.8

225.1

211.4

78.3

186.7

Total Inventory

628.1

503.3

445.0

273.2

700.8

Prepaid Expenses

4.8

2.1

10.9

2.2

11.2

    Deferred Income Tax - Current Asset

-

-

-

0.4

38.4

    Discontinued Operations - Current Asset

8.0

-

126.3

-

-

    Other Current Assets

1.2

6.0

7.9

13.5

87.6

Other Current Assets, Total

9.3

6.0

134.2

14.0

126.0

Total Current Assets

2,450.7

1,573.5

1,641.2

691.7

2,558.5

 

 

 

 

 

 

        Buildings

-

-

-

175.8

213.5

        Land/Improvements

-

-

-

597.9

741.4

        Machinery/Equipment

-

-

-

754.7

703.5

        Construction in Progress

-

-

-

51.6

70.3

        Leases

-

-

-

6.3

9.5

        Other Property/Plant/Equipment

-

-

-

52.1

60.7

    Property/Plant/Equipment - Gross

-

-

-

1,638.4

1,798.9

    Accumulated Depreciation

-

-

-

-662.2

-624.5

Property/Plant/Equipment - Net

1,391.8

1,087.6

881.3

976.2

1,174.4

Goodwill, Net

18.7

16.0

16.7

12.4

32.4

Intangibles, Net

63.1

46.5

50.8

18.7

48.1

    LT Investment - Affiliate Companies

427.5

438.8

260.2

101.0

86.6

    LT Investments - Other

257.9

266.1

262.3

181.7

176.0

Long Term Investments

685.3

704.8

522.5

282.7

262.6

Note Receivable - Long Term

38.9

34.0

41.3

25.3

39.5

    Deferred Income Tax - Long Term Asset

1.4

6.3

1.6

15.1

29.4

    Other Long Term Assets

33.0

33.5

39.0

41.3

236.4

Other Long Term Assets, Total

34.4

39.7

40.6

56.3

265.8

Total Assets

4,683.0

3,502.2

3,194.3

2,063.3

4,381.4

 

 

 

 

 

 

Accounts Payable

673.0

332.0

264.9

182.3

764.6

Accrued Expenses

27.5

19.3

14.7

6.9

19.9

Notes Payable/Short Term Debt

703.3

796.0

849.6

81.7

706.7

Current Portion - Long Term Debt/Capital Leases

133.1

101.5

229.0

153.4

418.5

    Dividends Payable

0.0

0.0

0.0

0.0

0.0

    Customer Advances

13.1

12.5

8.7

261.7

237.6

    Security Deposits

7.1

6.3

4.2

4.5

26.4

    Income Taxes Payable

27.4

24.1

56.3

15.0

49.0

    Other Payables

178.2

123.9

144.4

53.1

98.6

    Deferred Income Tax - Current Liability

-

-

-

60.6

0.2

    Discontinued Operations - Current Liability

1.2

-

-

-

-

    Other Current Liabilities

19.4

9.2

10.4

4.1

56.7

Other Current liabilities, Total

246.4

176.0

224.1

398.9

468.6

Total Current Liabilities

1,783.4

1,424.8

1,582.4

823.2

2,378.4

 

 

 

 

 

 

    Long Term Debt

1,118.0

528.1

203.4

295.0

775.8

    Capital Lease Obligations

-

-

-

5.9

3.5

Total Long Term Debt

1,118.0

528.1

203.4

300.8

779.3

Total Debt

1,954.5

1,425.6

1,282.0

535.9

1,904.6

 

 

 

 

 

 

    Deferred Income Tax - LT Liability

125.4

122.6

114.5

44.6

90.2

Deferred Income Tax

125.4

122.6

114.5

44.6

90.2

Minority Interest

420.0

339.1

314.0

105.7

395.2

    Reserves

0.9

2.0

2.0

0.8

0.8

    Pension Benefits - Underfunded

21.3

17.2

17.3

15.6

46.5

    Other Long Term Liabilities

4.1

0.9

0.9

-

17.6

Other Liabilities, Total

26.3

20.0

20.2

16.4

64.9

Total Liabilities

3,473.0

2,434.6

2,234.5

1,290.7

3,708.0

 

 

 

 

 

 

    Preferred Stock - Non Redeemable

13.2

12.2

12.4

12.1

11.2

Preferred Stock - Non Redeemable, Net

13.2

12.2

12.4

12.1

11.2

    Common Stock

97.7

90.5

91.8

89.5

82.7

Common Stock

97.7

90.5

91.8

89.5

82.7

Additional Paid-In Capital

131.0

122.0

122.9

256.7

229.8

Retained Earnings (Accumulated Deficit)

1,054.3

923.0

823.0

204.9

87.5

Treasury Stock - Common

-92.0

-85.1

-86.4

-67.1

-70.2

Unrealized Gain (Loss)

7.7

4.1

0.1

24.4

9.3

    Translation Adjustment

-0.8

2.1

-3.9

-0.4

35.9

    Other Equity

-1.2

-1.2

0.0

252.4

287.2

    Other Comprehensive Income

0.0

0.0

0.0

-

-

Other Equity, Total

-2.0

0.9

-3.9

252.0

323.1

Total Equity

1,210.0

1,067.6

959.9

772.6

673.4

 

 

 

 

 

 

Total Liabilities & Shareholders’ Equity

4,683.0

3,502.2

3,194.3

2,063.3

4,381.4

 

 

 

 

 

 

    Shares Outstanding - Common Stock Primary Issue

17.6

17.6

17.6

18.0

17.6

Total Common Shares Outstanding

17.6

17.6

17.6

18.0

17.6

Treasury Shares - Common Stock Primary Issue

3.2

3.2

3.2

2.9

3.2

    Shares Outstanding - Preferred Stock Primary Issue

2.8

2.8

2.8

2.8

2.7

Total Preferred Stock Outstanding

2.8

2.8

2.8

2.8

2.7

Treasury Shares - Preferred Primary Issue

0.0

0.0

0.0

0.0

0.1

Employees

-

1,592

1,488

1,487

1,543

Number of Common Shareholders

-

-

31,323

32,191

25,155

Deferred Revenue - Current

13.1

12.5

8.7

261.7

237.6

Total Long Term Debt, Supplemental

1,254.1

631.1

-

446.3

1,192.0

Long Term Debt Maturing within 1 Year

133.2

101.5

-

150.9

414.5

Long Term Debt Maturing in Year 2

279.0

108.2

-

244.7

445.3

Long Term Debt Maturing in Year 3

155.3

211.6

-

42.9

312.7

Long Term Debt Maturing in Year 4

155.3

54.5

-

3.2

-

Long Term Debt Maturing in Year 5

155.3

-

-

-

-

Long Term Debt Maturing in 2-3 Years

434.3

319.8

-

287.6

757.9

Long Term Debt Maturing in 4-5 Years

310.6

54.5

-

3.2

-

Long Term Debt Matur. in Year 6 & Beyond

376.0

155.3

-

4.6

19.5

    Interest Costs

-

-

-

-

-0.2

Total Capital Leases, Supplemental

-

-

-

8.4

7.5

Capital Lease Payments Due in Year 1

-

-

-

2.5

4.2

Capital Lease Payments Due in Year 2

-

-

-

1.5

0.9

Capital Lease Payments Due in Year 3

-

-

-

1.5

0.9

Capital Lease Payments Due in Year 4

-

-

-

1.5

0.9

Capital Lease Payments Due in Year 5

-

-

-

1.5

0.9

Capital Lease Payments Due in 2-3 Years

-

-

-

2.9

1.7

Capital Lease Payments Due in 4-5 Years

-

-

-

2.9

1.7

Total Operating Leases, Supplemental

-

0.1

-

2.2

2.3

Operating Lease Payments Due in Year 1

-

0.0

-

0.1

0.1

Operating Lease Payments Due in Year 2

-

0.0

-

0.1

0.1

Operating Lease Payments Due in Year 3

-

0.0

-

0.1

0.1

Operating Lease Payments Due in Year 4

-

0.0

-

0.1

0.1

Operating Lease Payments Due in Year 5

-

0.0

-

0.1

0.1

Operating Lease Pymts. Due in 2-3 Years

-

0.0

-

0.2

0.2

Operating Lease Pymts. Due in 4-5 Years

-

0.0

-

0.2

0.2

Oper. Lse. Pymts. Due in Year 6 & Beyond

-

0.0

-

1.8

1.8

 

 

Annual Cash Flows

 

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Restated Normal
31-Dec-2011

Updated Normal
31-Dec-2009

Updated Normal
31-Dec-2008

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate (Period Average)

1126.848795

1107.891393

1156.281981

1276.385219

1100.562842

Auditor

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified with Explanation

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

Net Income/Starting Line

139.0

205.3

177.5

113.3

54.5

    Depreciation

59.2

51.7

27.0

39.1

62.7

Depreciation/Depletion

59.2

51.7

27.0

39.1

62.7

    Amortization of Intangibles

5.2

4.8

4.7

13.4

11.1

    Amortization of Acquisition Costs

-

-

-

-

2.8

Amortization

5.2

4.8

4.7

13.4

13.9

Deferred Taxes

-

-

-

18.0

8.6

    Unusual Items

-28.9

31.6

10.4

-151.1

-21.7

    Equity in Net Earnings (Loss)

-6.5

-68.3

-15.8

24.9

16.5

    Other Non-Cash Items

148.5

64.6

-108.1

21.3

94.4

Non-Cash Items

113.1

27.8

-113.5

-104.9

89.1

    Accounts Receivable

-131.8

-200.0

-22.4

-6.3

-522.1

    Inventories

-100.8

-76.3

11.2

-42.0

-329.1

    Prepaid Expenses

-2.9

9.4

-1.1

2.2

-1.5

    Other Assets

4.5

44.4

11.6

-19.6

2.6

    Accounts Payable

380.1

-5.0

6.8

-131.3

181.2

    Accrued Expenses

-0.1

0.1

6.4

-2.2

1.0

    Taxes Payable

8.6

0.3

-

-24.0

2.8

    Other Liabilities

-12.3

-15.8

-2.1

293.3

-73.5

    Other Assets & Liabilities, Net

0.0

-

-

-

-

    Other Operating Cash Flow

-92.2

-96.3

-42.8

-

-

Changes in Working Capital

52.9

-339.2

-32.4

70.3

-738.5

Cash from Operating Activities

369.3

-49.6

63.3

149.2

-509.7

 

 

 

 

 

 

    Purchase of Fixed Assets

-296.3

-304.4

-61.8

-77.0

-182.7

    Purchase/Acquisition of Intangibles

-17.4

-4.9

-3.5

-10.5

-36.2

Capital Expenditures

-313.8

-309.3

-65.3

-87.5

-218.9

    Sale of Fixed Assets

3.8

9.8

116.7

299.1

5.2

    Sale/Maturity of Investment

136.5

459.0

56.2

2,612.6

443.2

    Investment, Net

-2.5

-4.6

37.5

-

-

    Purchase of Investments

-10.9

-488.9

-42.8

-2,403.8

-601.7

    Sale of Intangible Assets

1.1

0.9

-

0.3

6.0

    Other Investing Cash Flow

-44.6

21.3

8.3

-19.3

-40.1

Other Investing Cash Flow Items, Total

83.4

-2.6

175.9

488.9

-187.3

Cash from Investing Activities

-230.4

-311.9

110.7

401.4

-406.2

 

 

 

 

 

 

    Other Financing Cash Flow

-5.1

0.2

-20.1

-95.1

-25.8

Financing Cash Flow Items

-5.1

0.2

-20.1

-95.1

-25.8

Total Cash Dividends Paid

-12.7

-14.1

-10.0

-113.3

-135.6

        Sale/Issuance of Common

-

12.7

-

20.0

5.5

        Repurchase/Retirement of Common

-2.5

-2.2

-17.3

-

-25.5

    Common Stock, Net

-2.5

10.5

-17.3

20.0

-20.0

        Sale/Issuance of Preferred

-

-

-

-

36.3

        Repurchase/Retirement of Preferred

-

-

-

-23.5

-25.4

    Preferred Stock, Net

-

-

-

-23.5

10.9

Issuance (Retirement) of Stock, Net

-2.5

10.5

-17.3

-3.5

-9.2

        Short Term Debt Issued

-

-

-

116.1

1,426.6

        Short Term Debt Reduction

-148.2

-

-

-624.5

-833.0

    Short Term Debt, Net

-148.2

32.3

163.8

-508.4

593.5

        Long Term Debt Issued

645.4

453.3

71.6

351.0

604.7

        Long Term Debt Reduction

-103.7

-234.7

-147.6

-351.3

-214.7

    Long Term Debt, Net

541.6

218.5

-76.0

-0.2

390.0

Issuance (Retirement) of Debt, Net

393.4

250.8

87.8

-508.6

983.5

Cash from Financing Activities

373.0

247.4

40.5

-720.5

812.9

 

 

 

 

 

 

Foreign Exchange Effects

0.1

-2.2

0.0

-

-

Net Change in Cash

512.1

-116.4

214.5

-169.9

-102.9

 

 

 

 

 

 

Net Cash - Beginning Balance

165.5

284.7

58.3

89.1

144.5

Net Cash - Ending Balance

677.5

168.3

272.8

51.8

103.3

Cash Interest Paid

53.4

36.7

22.5

-

-

Cash Taxes Paid

56.9

75.6

25.4

-

-

 

 

Annual Income Statement

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Reclassified Normal
31-Dec-2012

Restated Normal
31-Dec-2011

Restated Normal
31-Dec-2010

Restated Normal
31-Dec-2009

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate (Period Average)

1126.848795

1107.891393

1156.281981

1276.385219

1100.562842

Auditor

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified with Explanation

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

    Net Sales

-

-

-

1,090.6

1,516.3

    Finished Goods Revenues

1,348.3

1,446.2

1,227.4

-

-

    Merchandise Sales

6,715.0

6,527.3

20.4

-

-

    Other Revenue

65.6

28.2

14.1

-

-

    Adj. for Revenues

0.0

0.0

0.0

-

-

Total Revenue

8,128.9

8,001.7

1,261.9

1,090.6

1,516.3

 

 

 

 

 

 

    Costs of Goods & Services Sold

7,520.2

7,353.6

979.5

836.2

1,231.7

    Salaries & Wages

85.7

79.4

42.8

37.7

38.8

    Retirement & Severance Benefits

7.0

7.2

3.8

4.3

5.0

    Stock-Based Compensation

-

-

0.2

-

-

    Employee Benefits

16.0

17.3

8.9

6.2

7.2

    Travel Expense

13.2

12.0

6.1

5.3

6.1

    Communication Expense

1.2

1.2

0.8

0.7

0.9

    Utility Expense

5.3

5.2

0.5

0.2

0.2

    Taxes & Dues

14.3

16.3

1.8

1.3

1.3

    Rental Expense

9.9

9.7

0.7

0.6

0.7

    Depreciation

21.2

23.3

1.5

1.3

1.6

    Repair & Maintenance Expense

2.9

5.5

0.3

0.2

0.2

    Insurance Expense

1.9

1.6

0.3

0.3

0.3

    Entertainment Expense

2.7

2.8

2.1

2.4

3.2

    Shipping & Handling Expense

67.2

68.0

23.6

18.0

27.6

    Consumable Expense

3.0

6.1

0.9

1.0

1.2

    Damage Compensation Expense

-

-

-

-

0.0

    Vehicle Maintenance Expense

5.1

4.6

2.6

1.8

2.3

    Education & Training Expense

4.5

5.9

3.4

2.2

3.0

    Publication Expense

0.3

0.5

0.5

0.4

0.4

    Commissions

63.8

55.9

33.4

22.6

20.8

    R & D Expense

58.3

62.3

46.1

34.3

32.2

    Advertising Expense

15.5

13.1

4.1

3.4

6.6

    Sales Promotional Expense

7.6

8.1

17.0

15.5

15.2

    Overseas Branch Operating Expense

-

-

1.3

1.3

1.6

    Sales Commissions

11.3

7.3

9.6

5.9

6.2

    Expenses for Samples

-

-

-

1.3

4.0

    Sample Test Expense

1.2

1.5

1.6

-

-

    Building Maintenance Expense

0.0

0.0

0.0

-

-

    Activity Expense

0.0

0.0

0.0

-

-

    Packaging Expense

2.9

6.9

5.4

2.1

4.4

    Conference Expnese

0.4

0.6

2.0

1.1

1.6

    Technology Royalty Expense

6.2

6.0

-

-

-

    Expense of Allow. for DA

5.3

4.5

0.2

1.2

1.4

    Amort. of Intangibless

4.5

4.4

4.6

10.4

13.2

    Income Supplemental Expense

0.0

0.1

0.0

-

-

    Miscellaneous Expense

1.1

2.5

0.2

0.3

3.8

    Adj. for Other Selling & Admin. Expense

0.0

0.0

0.0

-

-

Total Operating Expense

7,959.8

7,793.3

1,205.8

1,019.5

1,442.8

 

 

 

 

 

 

    Interest Income

17.1

16.6

2.8

5.0

5.3

    Dividend Income

2.5

0.7

1.1

0.0

0.0

    Rental Income

22.3

21.4

3.1

2.5

2.9

    Commission Income

-

-

0.0

-

-

    Gain-Disposal of ST Marketable Sec.

-

-

-

-

0.1

    Gain on Foreign Currency Transaction

89.2

111.7

10.4

15.1

29.7

    Gain on Foreign Currency Translation

11.7

5.4

0.8

4.4

6.2

    Gain-Disposal of inventory

-

-

-

-

0.0

    Gain-Disposal of Sec. Avail. for Sale

3.3

3.0

5.4

-

-

    Gain-Disposal of Sec. Held-to-Maturity

5.1

-

-

-

-

    G-Inv Asset Disposal

-

-

-

149.7

17.0

    Gain on Valt of Derivatives

3.8

8.7

-

0.1

12.3

    Gain on Derivatives Transaction

112.9

104.5

2.4

2.1

6.3

    Rec. of Allow. for DA

-

-

0.5

0.1

0.3

    Gain on Disposal of PPT

2.1

2.6

0.5

2.8

1.2

    Gain on Disposal of Intangibless

0.0

0.1

-

-

6.0

    Rec. of Impmt Loss-Sec. Avail. for Sale

0.0

-

-

0.1

0.0

    Income Taxes Refunds

-

-

-

0.1

-

    Gain-Disposal of Raw Materials

-

-

-

0.1

0.5

    Gain-Sales of Test Products

-

-

-

0.1

0.0

    Income-Patent & Royalty

-

-

-

-

0.0

    Rec. of Negative Goodwill

-

-

152.4

-

1.8

    Interest Expense

-52.1

-38.5

-19.9

-37.2

-57.6

    Amortization-Discount on Debt Issuance

-

-

-

-0.5

-0.7

    Loss on Disposal of Trade Receivable

-0.1

0.0

0.0

0.0

-0.2

    Loss on Inventory Obsolescence

-

-

-0.2

-0.1

-

    Loss on Disposal of Inventory

-7.6

-3.2

-3.5

-7.3

-5.1

    Loss-Scrapping of inventory

-

-

-

-

-0.2

    Loss on Disposal of Intangibless

-0.1

-0.2

-

-

-

    Loss on Disposal of PPT

-1.5

-1.8

-10.3

-11.7

-0.3

    L-Inv Secs Reduction

-

-

-

-0.2

-3.1

    Loss-Reduction of Investment Assets

-

-

-

-0.6

0.0

    Loss on Valt of Derivatives

-15.5

-6.5

-

-2.3

-0.7

    Loss on Derivative Transaction

-174.7

-80.6

-2.3

-2.2

-45.0

    Impmt Loss-Fincl Instrm Avail. for Sale

-1.2

-3.1

-

-

-

    Loss-Disposal of F.A. Avail. for Sale

0.0

-5.9

-2.0

-

-

    L-Inv Asset Disposal

-

-

-

-0.9

0.0

    L-Bond Redemption

-

-

-

-3.2

-

    Other Allow. for DA

-0.1

-

-0.3

-0.8

-0.5

    Loss on Foreign Currency Transaction

-49.8

-124.9

-12.4

-19.8

-42.6

    Loss on Foreign Currency Translation

-2.5

-11.6

-1.0

-1.1

-18.8

    Donations Paid

-6.5

-15.1

-9.0

-16.0

-5.8

    Depreciation of Idle Asset not Operation

-

-

-

-0.2

-0.5

    Raw Material Disposal Cost

-

-

-

-0.1

-0.2

    Impmt Loss on PPT

-

-5.5

-

-1.6

0.0

    Impmt Loss on Intangibless

-0.6

-5.1

-0.2

-3.2

-0.9

    Miscellaneous Loss

-10.5

-2.4

-0.8

-2.1

-2.9

    Miscellaneous Income

10.4

11.0

8.3

11.3

6.7

    Gain on Disposal of Securities in Affili

36.2

0.8

-

-

-

    Loss on Disposal of Sec. in Afflt

-

-9.1

-

-

-

    Gain/Loss under Equity Method

6.5

68.3

15.8

-

-

    Gain under Equity Method

-

-

-

3.3

7.4

    Loss under Equity Method

-

-

-

-26.6

-19.3

    Adj. for Other Non-Operating Income

-

-

0.0

-

-

    Adj. for Other Non-Operating Expense

0.0

0.0

-

-

-

    Adj. for Finance Income

0.0

0.0

-

-

-

    Adj. for Finance Expense

0.0

0.0

0.0

-

-

Net Income Before Taxes

169.4

250.0

197.6

130.6

-27.2

 

 

 

 

 

 

Prov. for Income Taxes

30.5

44.7

20.1

23.6

1.9

Net Income After Taxes

139.0

205.3

177.5

107.0

-29.1

 

 

 

 

 

 

    Earning Before Acquisition of Subsidiary

-

-

-

-

-0.7

    Minority Interest

-68.2

-33.6

-1.5

-14.1

-49.3

Net Income Before Extra. Items

70.8

171.7

176.0

92.9

-79.2

    Gain/Loss on Discontinued Operations

0.0

-33.0

16.4

6.3

84.3

Net Income

70.8

138.7

192.3

99.2

5.1

 

 

 

 

 

 

    Preferred Dividends

-1.1

-1.1

-1.3

-1.2

-0.4

Income Available to Com Excl ExtraOrd

69.7

170.6

174.6

91.7

-79.5

 

 

 

 

 

 

Income Available to Com Incl ExtraOrd

69.7

137.6

191.0

98.0

4.8

 

 

 

 

 

 

Basic Weighted Average Shares

17.6

17.6

17.7

17.7

18.1

Basic EPS Excluding ExtraOrdinary Items

3.96

9.69

9.85

5.17

-4.40

Basic EPS Including ExtraOrdinary Items

3.96

7.82

10.77

5.53

0.26

Dilution Adjustment

0.0

0.0

0.0

-

-

Diluted Net Income

69.7

137.6

191.0

98.0

4.8

Diluted Weighted Average Share

17.6

17.6

17.7

17.7

18.1

Diluted EPS Excluding ExtraOrd Items

3.96

9.69

9.85

5.17

-4.40

Diluted EPS Including ExtraOrd Items

3.96

7.82

10.77

5.53

0.26

DPS-Ordinary Shares

0.35

0.36

0.43

0.39

0.09

Gross Dividends - Common Stock

-

-

7.6

7.0

1.6

Normalized Income Before Taxes

176.6

252.5

210.8

149.8

-28.0

 

 

 

 

 

 

Inc Tax Ex Impact of Sp Items

31.8

45.1

21.5

26.5

1.3

Normalized Income After Taxes

144.9

207.4

189.4

123.4

-29.3

 

 

 

 

 

 

Normalized Inc. Avail to Com.

75.6

172.6

186.5

108.1

-79.7

 

 

 

 

 

 

Basic Normalized EPS

4.29

9.80

10.52

6.09

-4.41

Diluted Normalized EPS

4.29

9.80

10.52

6.09

-4.41

Interest Expense, Supplemental

52.1

38.5

19.9

37.7

58.3

Interest Capitalized

-

-

-

-0.3

-0.6

Rental Expense, Supplemental

9.9

9.7

0.7

0.6

0.7

Advertising Expense, Supplemental

23.2

21.2

21.1

18.9

21.8

R&D Expense, Supplemental

58.3

62.3

46.1

34.3

32.2

Depreciation, Supplemental

59.2

51.2

27.0

39.3

63.2

Amort of Intangibles, Supplemental

5.2

4.8

4.7

10.2

12.9

Amort of Acquisition Costs, Supplemental

-

-

-

4.2

2.8

Amort of Negative Goodwill, Supplemental

-

-

-

-1.0

-1.8

 

 

Annual Balance Sheet

 

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Restated Normal
31-Dec-2011

Updated Normal
31-Dec-2009

Updated Normal
31-Dec-2008

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate

1066.400024

1152

1134.9

1164.475

1259.55

Auditor

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified with Explanation

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

    Cash & Cash Equivalents

716.0

161.9

277.9

56.7

90.3

    Current Fincl Instrm

16.1

14.6

45.4

54.3

98.3

    ST Investment Securities

-

-

-

-

0.5

    Fincl Assets at FVTPL

4.0

8.4

-

-

-

    Trade Receivable, Gross

997.7

801.6

658.4

270.4

1,403.4

    Allow. for DA for Trade Receivable

-9.0

-8.0

-7.1

-6.7

-92.7

    Account Receivable

45.1

37.6

32.3

20.8

207.7

    Allow. for DA for Account Receivable

-0.5

-0.5

-0.9

-

-

    Prepaid Income Taxes

0.7

0.2

0.0

10.2

0.1

    Current Loans

35.2

45.4

44.2

-3.9

10.3

    Allow. for DA for Current Loans

-0.4

-0.3

-0.4

-

-

    Accrued Income

3.9

1.3

1.1

0.5

2.6

    Allow. for DA for Accrued Income

-0.1

0.0

0.0

-

-

    Advance Payments

15.4

21.3

16.1

57.9

140.3

    Prepaid Expense

4.6

2.1

2.8

2.2

11.2

    Prepaid Value Added Taxes

0.2

0.0

8.1

-

-

    ST deferred Tax Asset

-

-

-

0.4

38.4

    Derivatives

-

-

5.6

9.7

11.1

    Merchandises

148.0

102.8

91.7

26.5

132.8

    Finished Goods

74.5

53.6

58.0

64.0

62.7

    Manufactured Goods

11.3

11.1

13.8

13.8

11.0

    Semi-finished Goods

29.0

27.6

5.6

22.0

12.1

    Work in Progress

27.1

23.7

31.0

23.1

29.1

    Residential Units in Progress

-

-

-

-

77.9

    Display Materials

-

-

-

-

0.8

    Miscellaneous Inventory

-

-

-

-

3.0

    CA Land

-

-

-

-

144.3

    Raw Materials

56.4

59.3

33.6

45.4

40.5

    Raw Materials in Transit, Current

-

-

-

-

0.9

    Goods in Transit

261.0

199.3

187.7

11.3

25.9

    Merchandises in Transit

-

-

-

-

0.1

    Supplies

5.3

4.5

7.3

9.1

17.6

    Other Inventories

0.1

0.0

0.3

-

-

    Finished Residential Units, Current

-

-

-

-

2.1

    Government Subsidy

-

-0.2

-0.4

-

-

    Other in Other Current Assets

1.2

6.2

2.7

3.8

76.5

    Current Guarantee Deposits

0.0

0.0

0.0

-

-

    Non-Current Assets Held for Sale

8.0

-

126.3

-

-

    Adj. for Trade & Other Receivable

0.0

-

0.0

-

-

    Adj. for Other Current Assets

0.0

-

0.0

-

-

    Adj. for Inventories

0.0

0.0

0.0

-

-

Total Current Assets

2,450.7

1,573.5

1,641.2

691.7

2,558.5

 

 

 

 

 

 

    Non-Current Fincl Instrm

0.1

0.8

1.0

0.0

1.3

    LT Invest Secs.

-

-

-

181.7

174.7

    Non-Current Securities Available-for-Sal

156.0

162.3

156.7

-

-

    Non-Current Securities Held-to-Maturitie

-

8.7

8.8

-

-

    Invmt in Affiliates

427.5

438.8

260.2

101.0

86.6

    Long-term Trade Receivables

-

-

-

23.6

27.4

    Non-Current Loans

39.8

35.2

41.3

1.7

12.1

    Allow. for DA for LT Loans

-0.8

-1.2

-

-

-

    Invmt in Properties

101.8

94.3

95.7

-

-

    Non-Current Deferred Income Taxes Assets

1.4

6.3

1.6

15.1

29.4

    Non-Current Guarantee Deposits

32.2

32.6

33.0

33.7

190.8

    Non-Current Prepaid Expense

0.2

0.1

0.2

-

-

    Capital Lease Assets

-

-

3.7

-

-

    Other in Other Non-Current Assets

-

0.8

2.1

7.6

45.6

    Land

-

-

-

597.9

741.4

    Buildings

-

-

-

133.9

177.9

    Buildings Depre.

-

-

-

-43.6

-49.0

    Structures

-

-

-

41.9

35.6

    Structure Depre.

-

-

-

-18.5

-17.0

    Machinery/Equip.

-

-

-

753.6

697.6

    Mach/Equip Depre

-

-

-

-557.7

-511.9

    Machinery/Equip.-Government Subsidies

-

-

-

-0.5

-0.6

    Transport Equip.

-

-

-

1.6

6.4

    Transport Deprec

-

-

-

-1.2

-3.9

    Construction in Progress

-

-

-

46.9

65.6

    Construction in Progress-Govern. Subsidy

-

-

-

-

-11.9

    Other Tangibles

-

-

-

52.1

60.7

    Deprec.-Other

-

-

-

-39.2

-41.2

    Capital Lease Assets

-

-

-

6.3

9.5

    Capital Lease Assets-Depreciation

-

-

-

-2.1

-1.5

    Machines in Transit

-

-

-

4.7

3.2

    Forestation

-

-

-

-

13.5

    Goodwill

18.7

16.0

16.7

12.4

33.9

    Negative Goodwill

-

-

-

-

-1.4

    Land Usufruct

0.3

0.3

0.3

-

-

    Membership Rights

31.8

24.4

27.3

-

-

    Industrial Property Rights

9.3

9.5

10.7

12.0

8.3

    Operating Rights

-

-

-

-

3.7

    Software, Intangible

-

-

-

0.4

14.9

    Development Cost

-

-

-

4.8

8.4

    Other Intangibless

21.8

12.3

12.7

1.5

12.9

    Property, Plant & Equipment, Net

1,391.8

1,087.6

881.3

-

-

    Other Non-Current Assets

0.6

-

-

-

-

    Adj. for LT Trade & Other Receivable

0.0

0.0

0.0

-

-

    Adj. for Intangibless

0.0

0.0

-

-

-

    Adj. for Other Non-Current Assets

-

0.0

0.0

-

-

Total Assets

4,683.0

3,502.2

3,194.3

2,063.3

4,381.4

 

 

 

 

 

 

    Current Trade Payable

673.0

332.0

264.9

182.3

764.6

    Current Borrowings

703.3

796.0

849.6

81.7

706.7

    Current Portion of Bonds

103.1

78.1

211.4

85.8

201.5

    Current Portion of Long-Term Borrowings

30.1

23.3

16.6

8.1

89.8

    Current Fincl Lease Liabilities

-

-

1.0

2.5

4.2

    Deferred Income Tax Credits

-

-

-

60.6

0.2

    Derivatives in Current Liabilities

16.3

6.3

4.9

0.0

0.8

    Withheld

3.0

2.8

5.3

3.5

21.2

    Other Payable

178.2

123.9

144.4

53.1

98.6

    Value Added Taxes Withheld

8.4

0.3

0.0

-

-

    Accrued Expense

19.1

19.0

14.7

6.9

19.9

    Advance from Customers, Current

13.1

12.4

8.7

261.6

237.6

    Unearned Income

-

0.0

0.0

0.0

0.0

    Income Taxes Payable

27.4

24.1

56.3

15.0

49.0

    Dividend Payable

0.0

0.0

0.0

0.0

0.0

    Guarantee Deposit Withheld

7.1

6.3

4.2

4.5

26.4

    Current Portion of Foreign Bonds

-

-

-

50.1

-

    Curr FC LT Liab.

-

-

-

6.9

123.0

    Rsv-Constructn L

-

-

-

-

12.4

    Rsv-Error Adjust

-

-

-

-

21.7

    Current Portion of Provision for Curren

0.1

0.0

-

-

-

    Other in Other Current Liabilities

-

0.1

0.3

-

-

    Other Current Liabilities

0.0

-

-

0.5

0.7

    Adj. for Current Trade & Other Payable

0.0

-

0.0

-

-

    Adj. for Other Current Liabilities

-

0.0

-

-

-

    Current Liabilities Held for Sale

1.2

-

-

-

-

Total Current Liabilities

1,783.4

1,424.8

1,582.4

823.2

2,378.4

 

 

 

 

 

 

    Bonds

897.4

458.5

149.4

197.5

572.3

    Disc. on Bonds of LT Liabilities

-

-

-

-0.4

-

    Non-Current Borrowings

220.7

69.6

54.0

25.7

109.8

    Foreign Curr LTD

-

-

-

72.1

43.8

    Capital Lease Liabilities

-

-

-

5.9

3.5

    Bonds in Foreign Currency

-

-

-

-

49.8

Total Long Term Debt

1,118.0

528.1

203.4

300.8

779.3

 

 

 

 

 

 

    Rental Secur Dep

-

-

-

-

16.6

    Non-Current Guarantee Deposits Withheld

0.8

0.7

0.8

-

-

    Non-Current Accrued Expense

0.1

0.1

0.0

-

-

    Retirement & Severance Benefits, Non-Cur

21.3

17.2

17.3

-

-

    Prov.for Retirement & Severance Benefits

-

-

-

47.0

46.5

    Deposit-Retirement Insurance

-

-

-

-31.0

-

    Transfer to National Pension Fund

-

-

-

-0.5

-

    Reserve-Sales Return

-

-

-

0.8

0.8

    Non-Current Prov.s

0.9

2.0

2.0

-

-

    Other Non-Current Liabilities

3.2

0.0

-

-

1.0

    Deferred Income Taxes, LT Liabilities

125.4

122.6

114.5

44.6

90.2

    Minority Interests

420.0

339.1

314.0

105.7

395.2

    Adj. for LT Trade & Other Payable

0.0

0.0

0.0

-

-

Total Liabilities

3,473.0

2,434.6

2,234.5

1,290.7

3,708.0

 

 

 

 

 

 

    Common Stock

97.7

90.5

91.8

89.5

82.7

    Preferred Stock

13.2

12.2

12.4

12.1

11.2

    Additional Paid in Capital

122.2

113.1

114.8

111.9

103.4

    Reserve for Assets Revaluation

-

-

-

123.2

113.9

    Other Capital Surplus

8.8

8.9

8.1

21.6

12.5

    Unappropriated Retained Earnings

-

-

-

179.8

64.4

    Treasury Stock

-92.0

-85.1

-86.4

-67.1

-70.2

    Gain-Revaluation

-

-

-

252.4

287.2

    Losses on Valuation of Securities Availa

-

2.1

-

14.2

-7.6

    Gain on Valt of Sec. Available-for-Sale

16.0

3.2

0.9

-

-

    Capital Change, Equity Method

-8.2

0.6

0.9

10.5

27.4

    Capital Change, Equity Method (Loss)

-

-1.8

-1.7

-

-

    Voluntary Reserve

-

-

-

23.1

21.4

    Legal Reserve

-

-

-

2.0

1.7

    Overseas Bus. Translation Debit/Credit

-0.8

2.1

-3.9

-0.4

35.9

    Losses on Valt of Derivatives

-

-

-0.1

-0.3

-10.5

    Consolidated Retained Earnings

1,054.3

923.0

823.0

-

-

    Consolidated Capital Adj.

-1.2

-1.2

-

-

-

    Adj. for Capital Surplus

0.0

0.0

0.0

-

-

    Adj. for Capital Adj.

0.0

0.0

0.0

-

-

    Adj.-Accum. Other Comprehensive Income

0.0

0.0

0.0

-

-

Total Equity

1,210.0

1,067.6

959.9

772.6

673.4

 

 

 

 

 

 

Total Liabilities & Shareholders' Equity

4,683.0

3,502.2

3,194.3

2,063.3

4,381.4

 

 

 

 

 

 

    S/O-Ordinary Shares

17.6

17.6

17.6

18.0

17.6

Total Common Shares Outstanding

17.6

17.6

17.6

18.0

17.6

T/S-Ordinary Shares

3.2

3.2

3.2

2.9

3.2

    S/O-Preference Shares

2.8

2.8

2.8

2.8

2.7

Total Preferred Shares Outstanding

2.8

2.8

2.8

2.8

2.7

T/S-Preference Shares

0.0

0.0

0.0

0.0

0.1

Deferred Revenue, Current

13.1

12.5

8.7

261.7

237.6

Full-Time Employees

-

1,592

1,488

1,487

1,543

Number of Common Shareholders

-

-

31,323

32,191

25,155

Long Term Debt due in Year 1

133.2

101.5

-

150.9

414.5

Long Term Debt due in Year 2

279.0

108.2

-

244.7

445.3

Long Term Debt due in Year 3

-

211.6

-

42.9

312.7

Long Term Debt due in Year 4

-

54.5

-

3.2

-

Long Term Debt due in Year 5

465.9

-

-

-

-

Long Term Debt Remaining

376.0

155.3

-

4.6

19.5

Total Long Term Debt, Supplemental

1,254.1

631.1

-

446.3

1,192.0

Capital Lease due in Year 1

-

-

-

2.5

4.2

Capital Lease due in Year 5

-

-

-

5.9

3.5

Interest Cost

-

-

-

-

-0.2

Total Capital Leases, Supplemental

-

-

-

8.4

7.5

Operating Lease due in Year 1

-

0.0

-

0.1

0.1

Operating Lease due in Year 5

-

0.1

-

0.3

0.4

Operating Lease Remaining

-

0.0

-

1.8

1.8

Total Operating Leases, Supplemental

-

0.1

-

2.2

2.3

 

Annual Cash Flows

 

Financials in: USD (mil)

 

 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Period Length

12 Months

12 Months

12 Months

12 Months

12 Months

UpdateType/Date

Updated Normal
31-Dec-2012

Updated Normal
31-Dec-2011

Restated Normal
31-Dec-2011

Updated Normal
31-Dec-2009

Updated Normal
31-Dec-2008

Filed Currency

KRW

KRW

KRW

KRW

KRW

Exchange Rate (Period Average)

1126.848795

1107.891393

1156.281981

1276.385219

1100.562842

Auditor

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

KPMG LLP

Auditor Opinion

Unqualified

Unqualified

Unqualified with Explanation

Unqualified with Explanation

Unqualified

 

 

 

 

 

 

Net Income or Loss

139.0

205.3

177.5

113.3

54.5

    Depreciation

59.2

51.7

27.0

39.1

62.7

    Amort.-Goodwill

-

-

-

-

2.8

    Amort. of Intangibles

5.2

4.8

4.7

13.4

11.1

    Expense of Allow. for DA

5.9

4.5

0.2

4.8

47.3

    Retirement and Severance Benefits

11.8

10.9

7.6

21.9

40.9

    Interest Expenses

52.1

38.5

19.9

1.3

2.4

    Corporate Taxes Expense

30.5

44.7

20.1

-

-

    Expenses of Allow. for Other DA

-

-

0.3

4.7

3.5

    Amort-Bond Discount

-

-

-

0.9

1.4

    Depreciation of Idle Asset not Operation

-

-

-

0.2

0.5

    Loss on Sale of Tangibles

1.5

1.8

10.3

14.3

0.5

    Loss on Sale of Intangibles

0.1

0.2

-

-

-

    Impmt Loss on Intangibless

0.6

5.1

0.2

3.2

0.9

    Impmt Loss on Tangibles

-

5.5

-

-

-

    Losses on Foreign Currency Translation

2.5

11.6

1.0

3.6

40.0

    Loss under Equity Method

-

1.5

0.5

28.2

19.5

    Stock-Based Compensation

-

0.1

0.2

-

-

    Loss-Investment Assets Disposal

-

-

-

0.9

1.5

    L-Scrap LT Inv Secs

-

-

-

0.8

-

    Loss-Sale of Fincl Asset Avail.-for-Sale

0.0

5.9

2.0

-

-

    Impmt Loss-Fincl Asset Avail.-for-Sale

1.2

3.1

-

-

-

    Loss on Sale of Invmt in Affiliates

-

9.1

-

-

-

    L-Bond Redemption

-

-

-

3.2

-

    Loss-Disposal of Investment Securities

-

-

-

0.0

-

    Loss-Derivatives Valuation

-

-

-

9.7

19.8

    Loss on Valt of Derivative Fincl Assets

15.5

6.5

-

-

-

    Loss-Valuation of Contract on Settlement

-

-

-

1.0

-

    Loss on Sale of Trade Receivables

0.1

0.0

0.0

0.0

-

    Losses on Valt of Inventories

1.5

4.3

0.2

-

2.2

    Loss on Sale of Inventory

7.6

3.2

3.5

7.4

4.8

    Loss on Depletion of Inventory

0.0

-

0.2

0.0

-

    Provision for Point Reserve

-

-

-

0.1

-

    Affiliates' Gain-Before Purchased

-

-

-

-

0.7

    Miscellaneous Loss

3.9

3.8

0.5

0.0

0.0

    Loss on Derivatives Transaction

174.7

80.6

2.3

-

-

    Merchandise Reserve

-

-

-

-

0.0

    Rec. of Losses on Valt of Inventories

-

-

-

-0.3

-

    Gains on Foreign Currency Translation

-11.7

-5.4

-0.8

-13.6

-24.4

    Gain on Valuation of Confirmed Contracts

-

-

-

-6.8

-

    Rec. of Negative Goodwill Amort.

-

-

-152.4

-1.0

-1.8

    Gain on Sale of Tangibles

-2.1

-2.6

-0.5

-31.6

-0.9

    Rec. of Impmt Loss on Tangibles

-

-0.1

-

-

-

    Rec. of Impmt Loss-FA Avail.-for-Sale

0.0

-

-

-

-

    Gain on Sale of Intangibles

0.0

-0.1

-

-

-6.2

    Gain on Invmt in Affiliates

-6.5

-69.8

-16.3

-3.3

-3.1

    Gain on Sale of Invmt in Affiliates

-36.2

-0.8

-

-

-

    Gain-Disposal of Investment Securities

-

-

-

-0.2

-18.2

    Gain on Sale of Sec. Available-for-Sale

-3.3

-3.0

-5.4

-

-

    G-Inv Asset Disp.

-

-

-

-149.7

-6.4

    Rec. of Allow. for DA

-0.5

-0.4

-0.5

-0.1

-19.5

    Gains on Valts of Derivatives Assets

-3.8

-8.7

-

-2.8

-25.4

    Gain on Derivatives Transaction

-112.9

-104.5

-2.4

-

-

    Recovery-Loss Reduct of Invest Security

-

-

-

-0.1

0.0

    Dividend Income

-2.5

-0.7

-1.1

-

-

    Miscellaneous Gain

-

-0.2

-0.2

-0.7

-

    Interest Income

-17.1

-16.6

-2.8

0.0

-

    Trade Receivables

-134.5

-205.8

-18.5

-10.5

-411.7

    Account Receivables

2.6

5.9

-3.8

4.5

-110.7

    Accrued Income

-

-

-0.2

-0.3

0.3

    Advance Payments

8.1

-5.8

2.4

-49.1

-104.3

    Inventory

-109.0

-70.6

8.8

7.2

-224.8

    Prepaid Income Taxes

-

0.0

0.0

-0.2

0.0

    Prepaid Expenses

-2.6

-0.5

-1.0

2.4

-1.5

    Non-Current Prepaid Expenses

-0.1

1.6

-

-

-

    Prepaid Value Added Taxes

-0.2

8.3

-

-

-

    Other Current Assets

4.3

-3.7

1.5

-19.2

2.1

    Other Non-Current Assets

0.2

48.0

0.1

-0.3

-

    ST Guarantee Deposit

-

0.0

-

-

-

    Decrease in Derivative Assets

-

0.0

10.0

-

0.6

    Deferred Taxes-Asset

-

-

-

-0.1

16.4

    Deferred Income Tax Debit, Current

-

-

-

65.5

-8.6

    Government Subsidy

-

-0.1

0.3

-0.4

9.4

    Trade Payable

334.9

1.6

16.9

-143.5

170.2

    Non-Current Other Payable

-

-

0.0

-

-

    Account Payable

45.1

-6.6

-10.0

12.1

11.0

    Current Portion-LT Account Payable

-

-

-

-

0.0

    Advance from Customers

3.1

4.5

2.3

-0.7

38.4

    Unearned Income

-

0.0

-

-

-

    Withholdings

0.0

-2.3

1.8

2.0

-0.9

    Accrued Expenses

-0.1

0.1

6.3

-2.2

1.0

    Non-Current Accrued Expenses

0.0

0.0

0.0

-

-

    Taxes Payable

-

-

-

-24.0

2.8

    Value Added Taxes Withholdings

8.6

0.3

-

-

-

    Derivatives in Liabilities

-

-

-

-0.1

-4.1

    Other Prov.s

-

-0.2

0.4

-0.1

-1.0

    Reserve-Contingent Loss

-

-

-

275.2

-78.3

    Guarantee Deposit Withholdings

0.3

2.2

-0.4

-3.2

-0.2

    Reserve-Construction Loss

-

-

-

-

-1.3

    Prov.s

-0.4

-

-

-3.7

-

    Other Current Liabilities

-0.1

0.0

0.3

41.2

5.6

    Other Non-Current Liabilities

-0.9

0.0

-

-

0.9

    Payment for Retirement Allow.

-5.5

-12.8

-5.0

-14.1

-37.8

    Retirement Insurance

-

-

-

-3.3

-5.4

    Reserve-National Pension

-

-

-

0.1

0.4

    Reserve-Severance & Retirement Benefit

-

-

-

0.2

0.2

    Reserve in Severance & Retirement Benefi

-

-

-

0.2

0.7

    Plan Assets

-10.1

-7.2

-1.8

-

-

    Government Subsidiry

1.2

-

-

-

-

    Deferred Taxes-Liab.

-

-

-

-47.3

0.8

    Overseas Business Translation Debit

-

-

-

-0.8

9.3

    Accrued Dividends

0.0

0.0

-

-

-

    Cash-Interest Received

14.6

14.0

2.7

-

-

    Cash-Interest Paid

-53.4

-36.7

-22.5

-

-

    Cash-Dividend Income

3.4

1.9

2.5

-

-

    Cash-Tax Paid

-56.9

-75.6

-25.4

-

-

    Adj. for Operating Activities

0.0

-

-

-

-

    Adj.-Operating Assets & Liabilities

-

-

-

-

-

Cash from Operating Activities

369.3

-49.6

63.3

149.2

-509.7

 

 

 

 

 

 

    Disposal in Current Loans

13.1

25.5

-

0.2

0.4

    Decrease in Non-Current Loans

-

0.1

0.2

0.7

33.4

    Dividend Income-Affiliates

-

-

-

2.6

3.7

    Decs in Non-Current Guarantee Deposit

2.9

4.9

12.9

2.7

5.2

    Increase in Government Subsidy

0.9

0.9

-

-

-

    Decrease-LT Trade Receivable

-

-

-

-

1.7

    Disposal of Derivative Assets

-

14.2

-

-

-

    Disposal of Current Financial Instrument

-

354.2

44.5

2,289.6

382.3

    Disposal of Non-Current Financial Instru

0.8

0.0

0.0

-

-

    Decr-ST Investment Assets

-

-

-

-

10.5

    Disp-LT investment Secs

-

-

-

0.7

41.7

    Disposal of Securities under Equity Meth

-

-

-

322.0

3.7

    Disposal of Investment in Affiliates

74.2

5.1

-

-

-

    Sale of Invmt in Subsidiaries

-2.3

75.7

7.9

-

-

    Decrease-Other LT Assets

-

-

-

0.3

5.1

    Disposal of Securities Available-for-Sal

55.0

23.9

3.9

-

-

    Sale of Fincl Assets Held to Maturity

8.9

-

-

-

-

    Cash Inflow from Mergers

0.5

-

-

-

-

    Decrease-Intangible Assets

-

-

-

0.3

6.0

    Disposal of Membership Right

1.0

0.5

-

-

-

    Disposal of Other Intangible Assets

0.1

0.4

-

-

-

    Disp Tangible Assets

-

-

-

299.1

5.2

    Disposal of Other Tangible Assets

1.8

0.6

0.1

-

-

    Disposal of Land

0.3

5.7

104.0

-

-

    Disposal of Buildings

0.8

3.3

0.1

-

-

    Disposal of Structures

0.1

0.0

0.9

-

-

    Disposal of Machinery

0.7

0.1

10.5

-

-

    Disposal of Vehicles

0.0

0.2

0.0

-

-

    Disposal of Construction in Progress

-

0.0

0.8

-

-

    Disposal of Machines in Transit

-

-

0.2

-

-

    Purchase of Current Fincl Instruments

-0.2

-323.1

-2.4

-2,272.3

-450.5

    Purchase of Non-Current Fincl Instrm

-

0.0

0.0

-

-0.1

    Inc-ST Inv Assets

-

-

-

-73.1

-

    Acq-LT Inv Secs

-

-

-

-47.7

-83.8

    Purchase of Other Invmt Assets

-

-0.1

-0.3

-

-

    Purchase of Invmt in Subsidiaries

-2.5

-4.6

37.5

-

-

    Purchase of Securities under Equity Meth

-

-

-

-10.7

-67.3

    Purchase of Invmt in Affiliates

-4.0

-137.3

-33.6

-

-

    Purchase of Sec. Available-for-Sale

-6.7

-28.4

-6.4

-

-

    Increase in Current Loans

-

-3.8

0.0

-0.1

-0.1

    Increase in Non-Current Loans

-2.1

-15.4

-

-15.0

-0.5

    Inc in Guarant Depos

-

-

-

-10.5

-84.0

    Incs in Non-Current Guarantee Deposit

-

-5.2

-4.8

-

-

    Increase in Current Guarantee Deposit

0.0

-

-

-

-

    Purchase of Derivatives Assets

-59.9

-

-

-

-

    Purchase of Tangibles

-

-

-

-77.0

-182.7

    Purchase of Land

-12.3

-29.0

-3.6

-

-

    Purchase of Buildings

-2.6

-1.1

-0.8

-

-

    Purchase of Structures

-4.1

-0.6

0.0

-

-

    Purchase of Machinery

-15.2

-5.8

-0.8

-

-

    Purchase of Vehicles

-0.3

-0.2

0.0

-

-

    Purchase of Construction in Progress

-254.9

-243.6

-49.9

-

-

    Purchase of Machines in Transit

-1.2

-19.7

-5.1

-

-

    Purchase of Other Tangibless

-5.8

-4.4

-1.5

-

-

    Purchase of Intangibless

-

-

-

-10.5

-36.2

    Purchase of Industrial Property Right

-3.1

-2.6

-2.7

-

-

    Purchase of Land Usufruct

-

0.0

-

-

-

    Purchase of Membership Right

-6.8

-1.8

-0.4

-

-

    Purchase of Other Intangibless

-7.6

-0.5

-0.4

-

-

Cash from Investing Activities

-230.4

-311.9

110.7

401.4

-406.2

 

 

 

 

 

 

    Inc in ST Borrowings

-

-

-

116.1

1,426.6

    Increase-Capital Lease Liabilities

-

-

-

-

10.9

    Increase in Bonds

479.2

404.5

68.9

324.2

418.1

    Disp-Treasury Stock

-

-

-

20.0

-

    Issuance of Preferred Stock

-

-

-

-

36.3

    Increase-Capital Increase Price

-

-

-

-

35.0

    Increase-Rent Guarantee Deposit

-

-

-

2.5

11.9

    Increase in Non-Current Borrowings

166.2

48.7

2.7

26.9

175.7

    Rights Issue

-

12.7

-

-

5.5

    Dec of ST Borrowings

-148.2

-

-

-624.5

-833.0

    Expense for New Stock Issurance

-

-

-

-10.2

-11.8

    Decrease in Current Portion of Bonds

-79.9

-223.7

-137.0

-112.8

-119.0

    Decs in Current Portion of LT Borrowings

-23.9

-10.0

-8.1

-83.1

-35.7

    Decr-Current Prot-For. LT Liab.

-

-

-

-8.0

-42.3

    Dec-Current Portion of Asset-Backed Debt

-

-

-

-

-10.9

    Dec-Bonds

-

-

-

-151.9

-27.3

    Decrease in Capital Lease Liabilities

-

-1.0

-2.5

-3.5

-4.4

    Dec in LT Borrowings

-

-

-

-

-12.2

    Dec-For Curr LT Brrw.

-

-

-

-

-5.3

    Dec-LT Account Pay.

-

-

-

-0.4

-

    Capital Reduction

-2.5

-2.2

-

-

-

    Increase in Treasury Stocks

-

-

-17.3

-

-25.5

    Dec-Redeem Prfrd Stk

-

-

-

-23.5

-25.4

    Overseas Business Translation Effect

-5.1

0.2

0.2

-

-

    Decrease-Lease Guarantee Deposit

-

-

-

-2.2

-

    Cash Inflow-Consol. Scope Change, FN

-

-

-

-76.8

-18.6

    Cash Flow from Discontinued Operations

-

-

-20.3

-

-

    Dividend Paid

-12.7

-14.1

-10.0

-113.3

-135.6

    Current Borrowings, Net

-

32.3

163.8

-

-

Cash from Financing Activities

373.0

247.4

40.5

-720.5

812.9

 

 

 

 

 

 

Foreign Exchange Effects

0.1

-2.2

0.0

-

-

Incs or Decs in Cash & Cash Equivalents

512.1

-116.4

214.5

-169.9

-102.9

 

 

 

 

 

 

Cash and Cash Equivalents at Beginning

165.5

284.7

58.3

89.1

144.5

Cash and Cash Equivalents at End

677.5

168.3

272.8

51.8

103.3

    Cash Interest Paid

53.4

36.7

22.5

-

-

    Cash Taxes Paid

56.9

75.6

25.4

-

-

 

 

 

Financial Health

 

Financials in: USD (mil)

 

Except for share items (millions) and per share items (actual units)

 

 

Key Indicators USD (mil)

 

Quarter
Ending
31-Mar-2013

Quarter
Ending
Yr Ago

Annual
Year End
31-Dec-2012

1 Year
Growth

3 Year
Growth

5 Year
Growth

Total Revenue1 (?)

1,739.4

-19.31%

8,128.9

3.33%

87.39%

10.04%

Research & Development1 (?)

-

-

58.3

-4.80%

14.56%

12.00%

Operating Income1 (?)

32.9

-31.20%

169.2

-17.43%

28.05%

-8.21%

Income Available to Common Excl Extraord Items1 (?)

-25.8

-

69.7

-58.45%

-12.46%

9.22%

Basic EPS Excl Extraord Items1 (?)

-1.46

-

3.96

-58.45%

-12.25%

10.15%

Capital Expenditures2 (?)

40.2

-74.04%

313.8

3.17%

46.84%

24.75%

Cash from Operating Activities2 (?)

-4.1

-

369.3

-

29.78%

-

Free Cash Flow (?)

-43.2

-

58.7

-

-7.37%

-

Total Assets3 (?)

4,218.4

8.11%

4,683.0

23.78%

27.62%

4.80%

Total Liabilities3 (?)

3,075.1

11.82%

3,473.0

32.05%

35.07%

1.38%

Total Long Term Debt3 (?)

1,009.6

30.00%

1,118.0

95.98%

50.42%

8.06%

Employees3 (?)

-

-

-

-

-

-

Total Common Shares Outstanding3 (?)

17.6

0.00%

17.6

0.00%

-0.67%

-0.84%

1-ExchangeRate: KRW to USD Average for Period

1084.553644

 

1126.848795

 

 

 

2-ExchangeRate: KRW to USD Average for Period

1084.553644

 

1126.848795

 

 

 

3-ExchangeRate: KRW to USD Period End Date

1112.840072

 

1066.400024

 

 

 

Key Ratios

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Profitability

Gross Margin (?)

6.74%

7.77%

21.50%

23.33%

18.77%

Operating Margin (?)

2.08%

2.60%

4.44%

6.52%

4.84%

Pretax Margin (?)

2.08%

3.12%

15.66%

11.97%

-1.79%

Net Profit Margin (?)

0.86%

2.13%

13.84%

8.41%

-5.25%

Financial Strength

Current Ratio (?)

1.37

1.10

1.04

0.84

1.08

Long Term Debt/Equity (?)

0.92

0.49

0.21

0.39

1.16

Total Debt/Equity (?)

1.62

1.34

1.34

0.69

2.83

Interest Coverage (?)

-

2,098,839,565.00

249,377,947.23

-

-

Management Effectiveness

Return on Assets (?)

3.47%

5.94%

6.81%

3.45%

-0.68%

Return on Equity (?)

6.30%

16.50%

20.60%

13.61%

-13.33%

Efficiency

Receivables Turnover (?)

8.50

9.65

2.50

1.23

0.99

Inventory Turnover (?)

13.56

15.02

2.75

1.78

1.93

Asset Turnover (?)

2.03

2.31

0.48

0.35

0.35

Market Valuation USD (mil)

Enterprise Value2 (?)

2,485.7

.

Price/Sales (TTM) (?)

0.11

Enterprise Value/Revenue (TTM) (?)

0.32

.

Price/Book (MRQ) (?)

0.61

Enterprise Value/EBITDA (TTM) (?)

10.95

.

Market Cap1 (?)

842.3

1-ExchangeRate: KRW to USD on 23-Aug-2013

1120.273878

 

 

 

2-ExchangeRate: KRW to USD on 31-Mar-2013

1112.840072

 

 

 

 

 

Annual Ratios

 

Financials in: USD (mil) 

Except for share items (millions) and per share items (actual units)           



 

 

31-Dec-2012

31-Dec-2011

31-Dec-2010

31-Dec-2009

31-Dec-2008

Financial Strength

Current Ratio (?)

1.37

1.10

1.04

0.84

1.08

Quick/Acid Test Ratio (?)

1.01

0.75

0.66

0.49

0.72

Working Capital1 (?)

667.4

148.7

58.8

-131.5

180.2

Long Term Debt/Equity (?)

0.92

0.49

0.21

0.39

1.16

Total Debt/Equity (?)

1.62

1.34

1.34

0.69

2.83

Long Term Debt/Total Capital (?)

0.35

0.21

0.09

0.23

0.30

Total Debt/Total Capital (?)

0.62

0.57

0.57

0.41

0.74

Interest Coverage (?)

-

2,098,839,565.00

249,377,947.23

-

-

Payout Ratio (?)

8.97%

3.73%

4.39%

7.58%

-2.07%

Effective Tax Rate (?)

17.98%

17.88%

10.19%

18.04%

-

Total Capital1 (?)

3,164.5

2,493.2

2,241.9

1,308.5

2,578.0

 

 

 

 

 

 

Efficiency

Asset Turnover (?)

2.03

2.31

0.48

0.35

0.35

Inventory Turnover (?)

13.56

15.02

2.75

1.78

1.93

Days In Inventory (?)

26.91

24.30

132.63

205.32

188.84

Receivables Turnover (?)

8.50

9.65

2.50

1.23

0.99

Days Receivables Outstanding (?)

42.92

37.81

145.73

297.36

369.93

Revenue/Employee2 (?)

-

4,833,721

864,017

803,922

858,629

Operating Income/Employee2 (?)

-

125,886

38,395

52,430

41,593

EBITDA/Employee2 (?)

-

159,664

60,114

88,955

84,730

 

 

 

 

 

 

Profitability

Gross Margin (?)

6.74%

7.77%

21.50%

23.33%

18.77%

Operating Margin (?)

2.08%

2.60%

4.44%

6.52%

4.84%

EBITDA Margin (?)

2.87%

3.30%

6.96%

11.07%

9.87%

EBIT Margin (?)

2.08%

2.60%

4.44%

6.52%

4.84%

Pretax Margin (?)

2.08%

3.12%

15.66%

11.97%

-1.79%

Net Profit Margin (?)

0.86%

2.13%

13.84%

8.41%

-5.25%

R&D Expense/Revenue (?)

0.72%

0.78%

3.65%

3.14%

2.12%

COGS/Revenue (?)

92.51%

91.90%

77.62%

76.67%

81.23%

SG&A Expense/Revenue (?)

4.36%

4.34%

13.78%

12.56%

10.57%

 

 

 

 

 

 

Management Effectiveness

Return on Assets (?)

3.47%

5.94%

6.81%

3.45%

-0.68%

Return on Equity (?)

6.30%

16.50%

20.60%

13.61%

-13.33%

 

 

 

 

 

 

Valuation

Free Cash Flow/Share2 (?)

3.33

-19.61

-0.11

3.76

-36.07

Operating Cash Flow/Share 2 (?)

22.17

-2.71

3.66

9.10

-25.24

1-ExchangeRate: KRW to USD Period End Date

1066.400024

1152

1134.9

1164.475

1259.55

2-ExchangeRate: KRW to USD Average for Period

1066.400024

1152

1134.9

1164.475

1259.55

 

Current Market Multiples

Market Cap/Earnings (TTM) (?)

-102.62

Market Cap/Equity (MRQ) (?)

0.74

Market Cap/Revenue (TTM) (?)

0.11

Market Cap/EBIT (TTM) (?)

5.41

Market Cap/EBITDA (TTM) (?)

3.74

Enterprise Value/Earnings (TTM) (?)

-300.83

Enterprise Value/Equity (MRQ) (?)

2.17

Enterprise Value/Revenue (TTM) (?)

0.32

Enterprise Value/EBIT (TTM) (?)

15.86

Enterprise Value/EBITDA (TTM) (?)

10.95

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs. 61.58

UK Pound

1

Rs. 101.09

Euro

1

Rs. 83.99

 

 

INFORMATION DETAILS

 

Report Prepared by :

DPT

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.